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A B S T R A C T
Background
Nicotine replacement therapy (NRT) delivers nicotine without the toxic chemicals present in tobacco smoke. It is an eGective smoking
cessation aid in non-pregnant smokers, but there is less evidence of eGectiveness in pregnancy. Systematic review evidence suggests that
pregnant women do not adhere to NRT as prescribed, which might undermine eGectiveness. Electronic cigarettes (e-cigarettes) have grown
in popularity, but eGectiveness and safety in pregnancy are not yet established. The determinants of uptake and use of NRT and e-cigarettes
in pregnancy are unknown.
Objectives
To explore factors aGecting uptake and use of NRT and e-cigarettes in pregnancy.
Search methods
We searched MEDLINE(R), CINAHL and PsycINFO on 1 February 2019. We manually searched OpenGrey database and screened references
of included studies and relevant reviews. We also conducted forward citation searches of included studies.
Selection criteria
We selected studies that used qualitative methods of data collection and analysis, included women who had smoked in pregnancy, and
elicited participants' views about using NRT/e-cigarettes for smoking cessation or harm reduction (i.e. to smoke fewer cigarettes) during
pregnancy.
Data collection and analysis
We identified determinants of uptake and use of NRT/e-cigarettes in pregnancy using a thematic synthesis approach. Two review authors
assessed the quality of included studies with the Wallace tool. Two review authors used the CERQual approach to assess confidence in
review findings. The contexts of studies from this review and the relevant Cochrane eGectiveness review were not similar enough to fully
integrate findings; however, we created a matrix to juxtapose findings from this review with the descriptions of behavioural support from
trials in the eGectiveness review.
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Main results
We included 21 studies: 15 focused on NRT, 3 on e-cigarettes, and 3 on both. Studies took place in five high-income countries. Most
studies contributed few relevant data; substantially fewer data were available on determinants of e-cigarettes. Many studies focused
predominantly on issues relating to smoking cessation, and determinants of NRT/e-cigarette use was oKen presented as one of the themes.
We identified six descriptive themes and 18 findings within those themes; from these we developed three overarching analytical themes
representing key determinants of uptake and adherence to NRT and/or e-cigarettes in pregnancy. The analytical themes show that
women's desire to protect their unborn babies from harm is one of the main reasons they use these products. Furthermore, women consider
advice from health professionals when deciding whether to use NRT or e-cigarettes; when health professionals tell women that NRT or e-
cigarettes are safer than smoking and that it is okay for them to use these in pregnancy, women report feeling more confident about using
them. Conversely, women who are told that NRT or e-cigarettes are as dangerous or more dangerous than smoking and that they should
not use them during pregnancy feel less confident about using them. Women's past experiences with NRT can also aGect their willingness
to use NRT in pregnancy; women who feel that NRT had worked for them (or someone they know) in the past were more confident about
using it again. However, women who had negative experiences were more reluctant to use NRT.
No trials on e-cigarette use in pregnancy were included in the Cochrane eGectiveness review, so we considered only NRT findings when
integrating results from this review and the eGectiveness review. No qualitative studies were conducted alongside trials, making full
integration of the findings challenging. Women enrolled in trials would have agreed to being allocated to NRT or control group and would
have received standardised information on NRT at the start of the trial. Overall, the findings of this synthesis are less relevant to women's
decisions about starting NRT in trials and more likely to help explain trial participants' adherence to NRT aKer starting it.
We considered most findings to be of moderate certainty; we assessed findings on NRT use as being of higher certainty than those on e-
cigarette use. This was mainly due to the limited data from fewer studies (only in the UK and USA) that contributed to e-cigarette findings.
Overall, we judged studies to be of acceptable quality with only minor methodological issues.
Authors' conclusions
Consistent messages from health professionals, based on high-quality evidence and clearly explaining the safety of NRT and e-cigarettes
compared to smoking in pregnancy, could help women use NRT and e-cigarettes more consistently/as recommended. This may improve
their attitudes towards NRT or e-cigarettes, increase their willingness to use these in their attempt to quit, and subsequently encourage
them to stay smoke-free.
P L A I N   L A N G U A G E   S U M M A R Y
Factors a6ecting use of nicotine replacement therapy and e-cigarettes in pregnancy
What was studied in this review? Nicotine replacement therapy (NRT) delivers nicotine without the harmful chemicals found in tobacco
smoke. NRT helps some non-pregnant adults to stop smoking, but it does not seem to work so well in pregnancy. This may be because
pregnant women generally do not use NRT as prescribed. Studies show that some pregnant women use e-cigarettes to help them cut
down or quit, although their safety and eGectiveness in pregnancy is not known. Little is known about the issues that influence pregnant
women's use of NRT/e-cigarettes.
What is the aim of this review? To explore factors that aGect whether women take up and use NRT or e-cigarettes to reduce or quit smoking
in pregnancy.
What are the key messages of this review? Three main factors influence whether women take up and use NRT and e-cigarettes in
pregnancy: advice women receive from health professionals on using NRT or e-cigarette in pregnancy, women's desire to protect their
unborn baby from harm, and past personal experience with NRT. Each of these factors can either encourage or discourage women from
using these products.
What are the key findings? We included 21 studies; 15 of these focused on NRT, 3 on e-cigarettes and 3 on both. Our findings suggest
that women's desire to protect their unborn babies from harm is one of the main reasons they use these products. They also consider
the advice from their health professionals; when professionals tell women that NRT or e-cigarettes are safer than smoking and that it
is okay to use them in pregnancy, their confidence about using them increases. When women are told that NRT or e-cigarettes are as
dangerous or more dangerous than smoking and that they should not use them when they are pregnant, they feel less confident about
using them. Women's past experiences with NRT will also aGect how willing they are to use NRT in pregnancy. For example, women who
feel that NRT had worked for them (or someone they know) in the past were more confident about using it again. However, women who
had negative experiences were more reluctant to use NRT. We conclude that consistent messages that are based on high-quality research
and clearly explain how safe NRT and e-cigarettes are compared to smoking in pregnancy, could help women use NRT and e-cigarettes
more consistently/as recommended. This may improve their attitudes towards NRT or e-cigarettes, increase their willingness to use these
in their attempt to quit, and encourage them to stay smoke-free.
How up-to-date is this review? We searched for studies that had been published before 1 February 2019.
Factors influencing the uptake and use of nicotine replacement therapy and e-cigarettes in pregnant women who smoke: a qualitative
evidence synthesis (Review)









Cochrane Database of Systematic Reviews
B A C K G R O U N D
Smoking in pregnancy remains an important public health issue.
Europe and regions of the Americas have the highest prevalence
in the world (Lange 2018), and in the UK around 1 in 10 women
are smoking at the time of childbirth (NHS Digital 2019). Smoking
is potentially preventable and associated with negative outcomes
for both the woman and the unborn child. Compared with
pregnant women who do not smoke, smokers face heightened
risks of placental abruption, miscarriage, still birth, ectopic
pregnancy, preterm labour, and low birthweight (Cnattingius
2004). Furthermore, a systematic review of randomised clinical
trials (RCTs) shows that stopping smoking in pregnancy improves
birth outcomes (Chamberlain 2017). There are also strong
intergenerational associations, with children of smokers more
likely to become smokers (Leonardi-Bee 2011). Tobacco smoking is
also a major risk factor for six of the eight leading causes of death
globally (WHO 2008).
Description of the topic
Nicotine replacement therapy (NRT) delivers nicotine without the
tar, carbon monoxide and other poisonous chemicals present in
tobacco smoke (IARC 2004). Numerous countries have smoking
cessation guidelines that recommend oGering pregnant smokers
NRT if behavioural support alone has not helped them to stop
smoking, including the UK (NICE 2010), Australia (Bar-Zeev 2018),
New Zealand (NZ Ministry of Health 2014), Canada (CAN-ADAPTT
2011), and the USA (ACOG 2017). In the UK, NRT is available
on prescription and cost-free to pregnant women (Smoking in
Pregnancy Challenge Group 2019). Between 2001 and 2012, 11% of
pregnant smokers in the UK received NRT prescriptions (Dhalwani
2014), and in 2015 all UK stop smoking services oGered NRT in
pregnancy (Cooper 2019). It is well established that NRT is eGective
outside of pregnancy (Hartmann-Boyce 2018), but it appears
less so in pregnancy (Coleman 2015). This is probably because
pregnant women generally do not use NRT for long enough or
in suGicient doses compared to non-pregnant smokers (Coleman
2015; Hollands 2013).
Encouraging greater use of NRT in pregnancy is logical and
ethical provided this promotes smoking cessation without causing
additional harm to the developing fetus. There is no biological
rationale for suspecting that NRT used in pregnancy could be more
harmful than smoking; it is more likely that NRT will be better for
pregnant women and their babies than smoking. NRT produces
none of the harmful products of combustion from tobacco smoke,
and nicotine and cotinine levels are lower when women use
NRT compared to smoking (Hickson 2018). There is no evidence
that NRT has any impact on birth outcomes (Chamberlain 2017).
Evidence from the largest trial of NRT used for smoking cessation in
pregnancy found that infants born to women in the NRT group were
more likely to have impairment-free development at two years of
age than those born to women in the placebo group (Cooper 2014).
In recent years, smokers wanting to reduce or stop smoking have
increasingly used electronic cigarettes (e-cigarettes); like NRT, e-
cigarettes deliver nicotine without the tobacco smoke. They work
by heating a solution that contains nicotine, propylene glycol
or glycerine, and flavourings to produce a vapour, without the
release of combustion products (McNeill 2015). Internationally,
non-pregnant smokers' use of e-cigarettes is increasing (Filippidis
2016; Gravely 2014; Mirbolouk 2018); in the European Union use has
risen from about 7.2% (95% CI 6.7% to 7.7%) in 2012 to 11.6% (95%
CI 10.9% to 12.3%) in 2014 (Filippidis 2016). In England, e-cigarettes
are the most popular aid to smoking cessation and are used in 37%
of quit attempts (West 2019).
Comparisons of toxic chemicals in the urine and saliva of non-
pregnant e-cigarette users versus smokers show significantly lower
levels of harmful chemicals among e-cigarette users (Shahab
2017). In 2018, Public Health England issued a report concluding
that e-cigarettes are considerably safer than continuing to smoke
(McNeill 2018). Furthermore, a systematic review of RCT data
shows that e-cigarettes were twice as eGective as placebo in
helping non-pregnant smokers stop smoking for at least six months
(risk ratio (RR) 2.29, 95% confidence interval (CI) 1.05 to 4.96,
placebo 4% vs e-cigarettes 9%) (Hartmann-Boyce 2016). Since the
above systematic review was published, another trial assessing
behavioural support plus either e-cigarettes or NRT for smoking
cessation in non-pregnant smokers found that nearly double the
people using e-cigarettes were able to quit (RR 1.83, 95% CI 1.30
to 2.58, NRT 9.9% vs e-cigarettes 18%) (Hajek 2019a). Unlike NRT,
in the UK e-cigarettes are a consumer product and not available
on prescription; users purchase them from designated vendors,
including specialist vaping shops, supermarkets, and newsagents.
However, some countries such as Canada and Australia have more
restrictive policies on their use (Yong 2017).
There are no published trials of e-cigarette use in pregnancy.
Cross-sectional studies from the USA indicate that prevalence of
e-cigarette use in all pregnant women ranges from 0.6% to 4.9%
(Kapaya 2019; Kurti 2017; Liu 2019; Mark 2015), but it is considerably
higher amongst pregnant women who smoke. For example, in a
nationally representative sample of women in the USA who smoke,
38.9% of pregnant women reported using e-cigarettes (Liu 2019). To
our knowledge, there is currently no published data on prevalence
of e-cigarette use in pregnancy available from other countries.
A narrative review of literature suggests that pregnant women
perceive e-cigarettes as less harmful than smoking and believe
these can aid smoking cessation (Breland 2019). These were also
the key reasons given by pregnant women for initiating the use of
e-cigarettes around the time of pregnancy (Kapaya 2019); however,
the determinants of sustained e-cigarette use are not known.
Why it is important to do this qualitative evidence
synthesis
It is important to understand why pregnant women choose to use
or not use NRT or e-cigarettes, the nature of any concerns they
might have about NRT or e-cigarette use, and how to address
these concerns. For NRT, such knowledge could help improve
pregnant women's adherence to NRT and could likely also improve
their chances of successfully quitting smoking (Raupach 2014). E-
cigarettes appear to have potential as a cessation aid (Hartmann-
Boyce 2016), and in some countries, such as the UK, expert health
professionals recommend supporting pregnant women who use
e-cigarettes in this way, especially if behavioural support and/
or NRT are ineGective or inappropriate (Smoking in Pregnancy
Challenge Group 2019). It is therefore also important to understand
the factors that influence pregnant women's use of e-cigarettes.
This qualitative evidence synthesis aims to provide an enhanced
understanding of pregnant women's perceptions around using NRT
or e-cigarettes.
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O B J E C T I V E S
To describe factors that influence pregnant women's uptake and
use of NRT or e-cigarettes for smoking cessation or harm reduction,
including barriers and facilitators; and to describe women's views
on and experiences of using NRT or e-cigarettes during pregnancy.
M E T H O D S
Inclusion criteria
Types of studies
We included empirical, non-review, qualitative studies, either
conducted alongside eGicacy trials or as 'stand-alone' studies,
using any qualitative design and appropriate methods of data
collection and data analysis. Mixed-methods studies were eligible if
they had a distinct section dedicated to qualitative data collection
and analysis and reported qualitative data.
Included studies explored views, opinions, and experiences of
pregnant women who smoke(d) in pregnancy on the use of any type
of NRT or e-cigarettes in pregnancy for smoking cessation or harm
reduction (i.e. using NRT or e-cigarettes to smoke fewer cigarettes).
Types of participants
Participants were either pregnant women who smoked at any point
during their pregnancy or women in the postpartum period who
had smoked in pregnancy. As we were interested in determinants of
use rather than just women's views aKer using NRT or e-cigarettes,
participants were not required to have previous experience using
NRT or e-cigarettes.
Settings
We included studies from any setting.
Phenomenon of interest
Factors influencing the uptake and subsequent use of NRT and
e-cigarettes during pregnancy, from the perspectives of pregnant
women.
Search strategy
We adopted a broad search strategy to include all relevant
qualitative studies. As a scoping exercise, we tried diGerent search
strategies in varied bibliographic databases to test the ability of
these to identify a selection of known research papers, which would
be appropriate for inclusion in the review. This exercise informed
the final selection of databases and of search terms, including
MeSH terms and key words used. Using database-appropriate
strategies based on the MEDLINE one, we searched MEDLINE Ovid
(1946 to 1 February 2019), CINAHL EBSCO (Cumulative Index to
Nursing and Allied Health Literature; 1937 to 1 February 2019) and
PsycINFO Ovid (1967 to 1 February 2019). All database strategies
presented in Appendix 1. Additionally, we manually searched
the OpenGrey database (http://www.opengrey.eu/ searched 1
February 2019) using terms 'pregnancy' AND 'smoking cessation'
and 'pregnancy' AND 'nicotine replacement' and screened
references of included studies and literature reviews identified
by searching. Finally, we conducted forward citation searches of
included studies.
Data collection and analysis
Selection of studies
We entered the identified studies into one Endnote database
and removed duplicates (EndNote X8), then we exported them to
Covidence, a screening and data extraction tool. Each title and
abstract was screened by two of the review authors (KB, KAC, TCH,
SLC, and SC), using a priori inclusion criteria (see Appendix 2). We
resolved conflicts through discussion where possible, involving a
third review author if necessary. For all potentially relevant studies,
two review authors independently assessed the full text, again
involving a third review author to resolve conflicts.
We recorded the following study characteristics on a specially
designed form.
• First study author.
• Date of publication.
• Language.
• Country and context of study (urban/rural).
• Sample size.
• Key participant characteristics (pregnancy status, smoking
status, NRT/e-cigarette user status, age, gestation, ethnicity,
socioeconomic data).
• Theoretical/conceptual perspective of the study.
• Data collection methods.
• Data analysis methods.
• Key themes reported by the authors.
We also screened the full text of manuscripts to identify and extract
any other data that might be of relevance to this review.
Appraisal of study quality
We used the Wallace quality appraisal criteria (Croucher 2003;
Wallace 2004; Appendix 3). Previous Cochrane qualitative evidence
syntheses, like Husk 2016, have used this tool. With it, the review
author assesses 13 criteria as being met ('yes'), not met ('no') or
uncertain ('cannot tell') (Husk 2016). For this study, eight criteria
relating to the research question were considered essential: clarity
of research question, appropriateness of study design, adequacy
of sample, adequacy of the population from which sample was
drawn, description of data collection, rigour of data collection,
rigour of analysis, and extent to which the data substantiated the
findings. The remaining five criteria were considered desirable:
clarity of theoretical perspective, adequacy of study context
description, reflexivity, claims regarding generalisability, and
adequately addressed ethical issues. Two review authors (KAC and
SLC) independently undertook the quality assessment and met to
discuss their ratings. Any disagreements were resolved through
discussion. Following recent guidance, which suggests that overall
ratings should not be assigned to qualitative studies (Munthe-Kaas
2018), we present specific methodological issues identified in each
study in Table 1.
In addition, we assessed studies for data richness (i.e. the amount
and depth of qualitative data that are relevant to the current
review), using a tool devised by Ames 2019. This tool uses a scale
of 1 to 5, where 1 indicates 'very few qualitative data which are
relevant to the review, and those presented are fairly descriptive'
and 5 indicates 'a large amount and depth of qualitative data
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relevant to the review'. See Appendix 4 for more details. We
assessed only the richness of data relevant to the review. For
example, a study focusing broadly on smoking cessation and
presenting large amounts of data on that topic might only present
one theme or part of a theme relating to NRT or e-cigarettes; we
would rate such a study 1 or 2, as there would be few qualitative
data relevant to this review. Richness of the data relevant to the
review did not aGect the quality assessment, as it did not reflect the
quality of the primary study, only how much it contributed to the
review.
Data extraction and analysis/synthesis
One review author (KAC) extracted data from included studies,
and another (SLC) checked them. This process acknowledged
that identifying the data or findings in qualitative studies can
be challenging (Noyes 2018). We followed the guidance from
Thomas 2008 and extracted study data reported as quotes from
participants, as well as key concepts, that is, summaries of findings
or any other relevant data presented in primary studies. We
assessed the whole text of each paper when searching for relevant
data. These data were extracted verbatim into NVivo soKware.
We used thematic synthesis described by Thomas 2008; this allows
inductive data coding and flexible data exploration to identify
concepts and constructs from within the data, which may not have
been predefined. We were also sensitive to the fact that derived
themes should relate to factors influencing uptake and use of NRT
and e-cigarettes and their acceptability as cessation aids. Synthesis
was conducted in three steps.
Steps one and two: line-by-line data coding and development of
descriptive themes
Initially KAC read all included studies to ascertain which ones
provided the potentially richest or most substantial data relevant to
the study questions. At this point it was clear that very few studies
of either NRT or e-cigarettes specifically investigated either the
barriers or facilitators for women using these (i.e. the determinants
of NRT or e-cigarette use). We decided therefore, that in order
to develop descriptive themes, we should carefully consider all
data for inferences about potential determinants of product use,
including data describing women's general views on or attitudes to
e-cigarettes and NRT.
AKer the initial read-through, 6/21 studies were considered likely
to provide the richest and most relevant data; we selected these
for initial detailed reading and sought to extract key concepts
and assign codes to the data (Ashwin 2010; Bowker 2016; Bowker
2018; Fallin 2016b; Hotham 2002; Taylor 2010). Next, two review
authors (KAC and KB) independently read these six primary
studies and inductively coded concepts arising from the data on
a line-by-line basis. Researchers first derived codes from Taylor
2010 and subsequently applied them to other studies whilst
simultaneously seeking new concepts and coding these, where
appropriate. However, once the initial 6 studies had been coded,
no new concepts were identified from the remaining 15 studies.
AKer independently coding all studies, the two researchers met,
discussed each other's emerging findings, refined coding and
agreed on new definitions and descriptions for each.
The researchers then looked for similarities and diGerences
between codes, grouped these into broader, descriptive themes,
and organised them hierarchically (Table 2). KAC recoded the entire
data set with the final, agreed codes. A third review author (TC)
then reviewed a document comprising all code definitions and
descriptive themes with definitions and discussed it with KAC and
KB in order to agree on a final version.
This process showed that data from the 15 primary studies were
limited, as all original concepts arising from the data had already
been identified from the six studies with richer data.
Step three: developing analytical themes
In the third step of the synthesis, we organised descriptive themes
into more abstract, analytical ones to help findings, as far as
possible, answer review questions. Two review authors (KAC and
KB) discussed descriptive themes and considered their relevance
to study questions. Through discussion, we identified further
analytical, overarching themes that encompassed the descriptive
ones and suggested barriers, facilitators, and other implications.
We then synthesised descriptive codes and themes to generate
analytical themes that directly answered review questions posed. A
third review author (TC) considered descriptions and definitions of
the derived analytical themes and discussed them with KAC and KB
prior to finalisation. We considered implications for future research
and practice in the context of the analytical themes.
The authors' perspective during the synthesis process, as described
in the reflexive note, is that we believe it is better for pregnant
women to use NRT or e-cigarettes than it is for them to smoke. This
belief is based on current evidence and guidance, which suggests
that:
• NRT is eGective for smoking cessation in the general population
(Hartmann-Boyce 2018);
• NRT used in pregnancy has no eGects on the birth outcomes
(Coleman 2015);
• NRT is recommended as a smoking cessation aid during
pregnancy (NICE 2010);
• New evidence suggests that e-cigarettes might be eGective for
smoking cessation in the general population (Hajek 2019a);
• E-cigarettes are likely to be significantly less harmful than
tobacco cigarettes, but are not without risk (McNeill 2018);
• Public Health England recommends e-cigarettes as a smoking
cessation aid for pregnant women who struggle to quit by other
means (McNeill 2018; Smoking in Pregnancy Challenge Group
2019).
Assessment of confidence in the review findings
To assess the confidence in the findings of this review, we applied
the Confidence in Evidence from Reviews of Qualitative research
method (CERQual) (Lewin 2015). This approach, developed by
GRADE-CERQual Project Group 2004, uses four components to
evaluate confidence in the review findings. These include the
methodological limitations of included studies, the relevance of
the included studies to review questions, the coherence of the
review findings, and the adequacy of the data that contributes
to each review finding. In the first instance, KAC evaluated each
finding using the four components of CERQual and a four-point
scoring system ranging from 'no or very minor concerns' to
'substantial concerns'; TCH then checked the evaluation. The
review authors met and discussed the scores and assigned each
finding an overall CERQual assessment score. Each finding started
with a 'high confidence' score which could be downgraded to
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'moderate confidence', 'low confidence' or 'very low confidence' if
the CERQual process revealed concerns.
Reflexive note
The review has been conducted from the epistemological stance
of critical realism, which assumes that our understanding of reality
is mediated by our beliefs and perceptions (Barnett-Page 2009). It
is therefore important to consider the characteristics of the review
authors, their beliefs and experiences, and how these might have
aGected the interpretation of the data throughout the synthesis
process. All review authors are researchers with backgrounds in
either primary health care, public health, psychology, sociology
and/or midwifery and have extensive experience conducting
research in the field of smoking cessation in pregnancy; none
are smokers or NRT or e-cigarette users. The review team is UK-
based, and this review was partially funded by National Institute
for Health and Care Excellence (NICE), a funder with a particular
interest in the UK context. In the UK, health authorities and/or
expert health professionals recommend use of NRT in pregnancy
(NICE 2010,Smoking in Pregnancy Challenge Group 2019), and they
support use of e-cigarettes as smoking cessation aids in pregnancy
(Smoking in Pregnancy Challenge Group 2019), which may have
had impact on the authors' views. To ensure rigour, the authors
considered the funder's interest as well as their own views and
beliefs about NRT and e-cigarettes and how these views could
aGect study conduct. At the outset, all authors viewed NRT and e-
cigarettes in pregnancy to be potentially valuable tools for smoking
cessation but were also aware of some of the issues pregnant
women experience in relation to using these and in particular
women's safety concerns. The review authors remained aware of
their views throughout the process of screening, data extraction,
and synthesis and attempted to treat all data equally and ensure
that contradictory findings were given equal place in the review.
R E S U L T S
Description of studies
The details of included studies appear in the Characteristics of
included studies tables. The Characteristics of excluded studies
tables show excluded studies and reasons for exclusion.
Results of the searches
Database searches were completed in February 2019. AKer
removing duplicates, there were 2449 unique titles and abstracts.
AKer initial screening, we considered 74 records to be potentially
relevant and retrieved 72 full texts (2 were unavailable), finally
including 21 studies. These consisted of a doctoral thesis (Taylor
2010), a health technology assessment with two chapters reporting
results relevant to this review (Bauld 2017), and 19 studies
published in scientific journals (Ashwin 2010, Borland 2013, Bovill
2018, Bowker 2016, Bowker 2018, Butterworth 2014, England 2016,
Fallin 2016b, Fallin 2016a, Gamble 2015, Glover 2012, Grant 2020,
Hauck 2013, Herbec 2014, Hotham 2002, Mantzari 2012, Naughton
2013, Pledger 2015, Radley 2013). Figure 1 presents the study
PRISMA diagram.
 
Factors influencing the uptake and use of nicotine replacement therapy and e-cigarettes in pregnant women who smoke: a qualitative
evidence synthesis (Review)









Cochrane Database of Systematic Reviews
Figure 1.   Study flow diagram
 
Study design
FiKeen studies used individual face-to-face or telephone interviews
to elicit data (Ashwin 2010; Bauld 2017; Borland 2013; Bowker 2016;
Bowker 2018; Gamble 2015; Glover 2012; Grant 2020; Hauck 2013;
Herbec 2014; Mantzari 2012; Naughton 2013; Pledger 2015; Radley
2013; Taylor 2010), five conducted focus groups (Butterworth 2014;
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England 2016; Fallin 2016b; Fallin 2016a; Hotham 2002), and one
used the yarning method of interviewing, which is an Indigenous
cultural form of establishing rapport and qualitative data collection
through conversation (Bovill 2018).
Study focus
FiKeen studies presented data relating to women's views on NRT
(Ashwin 2010; Borland 2013; Bovill 2018; Butterworth 2014; Fallin
2016a; Gamble 2015; Glover 2012; Hauck 2013; Herbec 2014;
Hotham 2002; Mantzari 2012; Naughton 2013; Pledger 2015; Radley
2013; Taylor 2010), three focused on e-cigarettes (Bowker 2018;
Fallin 2016b; Grant 2020), two on both (Bauld 2017; England 2016),
and one predominantly on NRT but with some views on e-cigarettes
(Bowker 2016). Participants' level of familiarity and engagement
with NRT and e-cigarettes varied across studies. Three studies
purposefully recruited all participants with experience of use of
NRT or e-cigarettes (Ashwin 2010; Bowker 2016; Fallin 2016b), while
in the other studies only some participants had experience of using
NRT, e-cigarette, or both.
Study context
All included studies were conducted in high-income countries:
12 in the UK (Ashwin 2010; Bauld 2017; Bowker 2016; Bowker
2018; Butterworth 2014; Grant 2020; Herbec 2014; Mantzari 2012;
Naughton 2013; Pledger 2015; Radley 2013; Taylor 2010), 4 in
Australia (Bovill 2018; Gamble 2015; Hauck 2013; Hotham 2002),
3 in the USA (England 2016; Fallin 2016a; Fallin 2016b), 1 in
New Zealand (Glover 2012), and 1 in Canada (Borland 2013).
Recruitment took place in a variety of settings, and some studies
recruited from more than one setting. Eight studies recruited
via maternity services or children's centres (Bauld 2017; Bowker
2016; Butterworth 2014; Fallin 2016a; Hauck 2013; Herbec 2014;
Naughton 2013; Taylor 2010), nine via smoking cessation services
or hotlines (Ashwin 2010; Bauld 2017; Borland 2013; Bowker 2016;
Bowker 2018; Butterworth 2014; Gamble 2015; Mantzari 2012;
Pledger 2015), three from local communities (Borland 2013; Bovill
2018; Grant 2020), two via indigenous health services (Bovill 2018;
Glover 2012), two via local or online advertising (Bowker 2018;
Glover 2012), one via a market research company (England 2016),
and one from an opioid dependence clinic (Fallin 2016a). Three
studies interviewed women who took part in trials or schemes
including smoking cessation interventions, although none of these
interventions focused primarily on NRT or e-cigarette provision/use
in pregnancy. Instead, the interventions were an online smoking
cessation intervention (Herbec 2014), financial incentives (Mantzari
2012), and financial incentives with free NRT provided at first
support session by a pharmacist (Radley 2013).
Participants
A total of 497 women participated in the included studies, ranging
from 6 in Gamble 2015 and Pledger 2015 to 60 in Glover 2012.
Nineteen studies reported participants' ages, which ranged from
15 to 49 years, with most participants being in their twenties.
All studies recruited pregnant women, and nine also included
women in the postpartum period. Six studies reported mean
gestational age, which ranged from 13 weeks to 24 weeks (Ashwin
2010; Bauld 2017; Bowker 2016; Bowker 2018; Butterworth 2014;
Gamble 2015), while in three studies the authors reported that
women in all trimesters were recruited (Bauld 2017; Bovill 2018;
Glover 2012). Eleven studies provided information on ethnicity;
in nine, participants were predominantly white (Bowker 2016;
Bowker 2018; Butterworth 2014; England 2016; Fallin 2016a; Hauck
2013; Herbec 2014; Mantzari 2012; Taylor 2010), whilst two studies
recruited only participants of Aboriginal, Torres Strait Island or
Maori origin (Bovill 2018; Glover 2012).
Studies were inconsistent in their collection and reporting of
socioeconomic status indicators; overall, the presented data
suggested that participants were from lower socioeconomic
groups. However, 10 studies did not report any data on this
variable (Ashwin 2010; Bauld 2017; Bovill 2018; Bowker 2016;
Fallin 2016a; Fallin 2016b; Hauck 2013; Herbec 2014; Hotham
2002; Pledger 2015). Five studies reported level of educational
achievement, which suggested that most women were not
educated beyond compulsory education or high school (Borland
2013; Bowker 2018; Butterworth 2014; England 2016; Glover 2012).
Five studies reported employment characteristics (Butterworth
2014; Glover 2012; Mantzari 2012; Naughton 2013; Taylor 2010),
four of which suggested that most participants were unemployed.
Naughton 2013 indicated that all women were employed,
with occupations varying from technical occupations to higher
managerial/professional occupations. One study reported that
80% of women had low income (Glover 2012), while three studies
indicated that participants lived in areas of the highest quintile of
deprivation and/or claimed means tested benefits (Gamble 2015;
Grant 2020; Radley 2013).
Support and funding for studies
None of the studies received funding from commercial sources, and
just one study declared conflicts of interest (Herbec 2014), with the
last author stating "RW undertakes consultancy and research for
and receives travel funds and hospitality from manufacturers of
medications for smoking cessation. He also undertakes training for
smoking cessation advisors and has a share of a patent for a novel
nicotine delivery device."
Quality assessment
Table 1 presents the outcomes of the quality appraisal (Wallace
2004). In all studies, the research question was clearly presented,
and the design was appropriate to the research question. All
studies except England 2016 drew the sample from an appropriate
population of pregnant women with some history of smoking
in pregnancy. In England 2016, the sample was drawn from a
marketing company database, and the characteristics of the wider
population were unclear. Several studies had some methodological
issues relating to insuGicient descriptions of the study sample
(Fallin 2016a; Fallin 2016b; Herbec 2014; Hotham 2002; Pledger
2015), data collection (Ashwin 2010; Bovill 2018; Fallin 2016a;
Glover 2012; Mantzari 2012; Pledger 2015; Radley 2013), or data
analysis (Ashwin 2010; England 2016; Fallin 2016a; Fallin 2016b;
Glover 2012; Hotham 2002; Pledger 2015). FiKeen studies did not
state the theoretical or ideological perspective (Borland 2013;
Bovill 2018; Bowker 2016; Bowker 2018; Butterworth 2014; England
2016; Fallin 2016a; Fallin 2016b; Glover 2012; Hauck 2013; Herbec
2014; Hotham 2002; Mantzari 2012; Pledger 2015; Radley 2013),
and another 15 did not suGiciently consider reflexivity (Ashwin
2010; Bauld 2017; Borland 2013; Bovill 2018; Butterworth 2014;
England 2016; Fallin 2016b; Glover 2012; Hauck 2013; Hotham 2002;
Mantzari 2012; Naughton 2013; Pledger 2015; Radley 2013; Taylor
2010).
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Confidence in the findings
We identified six descriptive themes that related to factors
influencing women's decisions about using or continuing to
use NRT and/or e-cigarettes. These were: safety concerns about
nicotine, concerns about the addictiveness of nicotine, beliefs
about the eGectiveness of nicotine-containing products, perceived
side eGects, influence of others, and characteristics of nicotine
products. Within these themes, we identified 18 unique findings
relating to the review questions. Table 2 presents a short overview
of these themes and the 18 related findings; Table 3 , a summary
of qualitative findings with overall CERQual assessments for each
finding; and Table 4, the matrix of qualitative findings. In Table
2, where there is no key finding within a theme, this is because
there were insuGicient data reported on the issue in empirical
studies. Hence, for findings 7 and 11, there were enough data
reported on concerns about addictiveness of nicotine and on side
eGects in the NRT studies to formulate key findings relating to NRT,
but insuGicient data for similar findings to arise in relation to e-
cigarettes.
Table 3 presents the assessment of confidence in review findings,
and Appendix 5 shows individual CERQual evidence profiles. We
also present an overall CERQual rating for each finding. Confidence
in findings ranged from 'high' to 'low', with most being ranked
as 'moderate' confidence. Findings were most oKen downgraded
where studies contributed thin/very thin data or data from few
participants, or because most studies contributing data to a finding
were from only one country, similar contexts, or the context of data
report was diGicult to establish. Findings were also downgraded
due to methodological issues with the primary studies, relating to
sample, data collection and analysis.
Factors influencing use of NRT and e-cigarettes in
pregnancy
Eighteen studies presented data on pregnant women's views about
NRT (Ashwin 2010; Bauld 2017; Borland 2013; Bovill 2018; Bowker
2016; Butterworth 2014; England 2016; Fallin 2016a; Gamble 2015;
Glover 2012; Hauck 2013; Herbec 2014; Hotham 2002; Mantzari
2012; Naughton 2013; Pledger 2015; Radley 2013; Taylor 2010).
Most presented data only on NRT, while three presented data on
both NRT and e-cigarettes (Bauld 2017; Bowker 2016; England
2016). Three studies presented data only on e-cigarettes (Bowker
2016; Fallin 2016b; Grant 2020). Six studies contributed rich or
moderately rich data relevant to the review questions set out in
Table 1 (Ashwin 2010; Bowker 2016; Bowker 2018; England 2016;
Hotham 2002; Taylor 2010). Four contributed thin data, for example
one substantial theme within a broader analysis (Bauld 2017; Bovill
2018; England 2016; Mantzari 2012), and eleven studies contributed
very thin data, for example, less than one theme or very short
theme with limited quotes (Borland 2013; Butterworth 2014; Fallin
2016a; Fallin 2016b; Gamble 2015; Glover 2012; Grant 2020; Hauck
2013; Herbec 2014; Naughton 2013; Pledger 2015; Radley 2013).
Theme 1: safety concerns about nicotine – women's beliefs
about safety of nicotine-containing products influence their
use in pregnancy
This theme related to barriers and facilitators relating to women's
concerns regarding safety of nicotine-containing products, a
concept women discussed in 15 studies (Ashwin 2010; Bauld 2017;
Borland 2013; Bovill 2018; Bowker 2016; Bowker 2018; Butterworth
2014; England 2016; Fallin 2016b; Glover 2012; Grant 2020; Hotham
2002; Naughton 2013; Radley 2013; Taylor 2010).
Finding 1: women believe that NRT is safer than smoking
Six studies found that women perceived NRT as safer than smoking,
as it only delivers nicotine and not the many harmful chemicals
present in cigarette smoke (Ashwin 2010; Bauld 2017; Bowker 2016;
Hotham 2002; Naughton 2013; Taylor 2010).
"With nicotine patches, you don't get the chemicals like you do with
cigarettes - the things that keep the paper burning and the this and
the that they chuck in. They [the patches] are actually better for you
- you're just getting the nicotine." G1 (Hotham 2002)
In two studies, some women felt that NRT was as harmful as
smoking (England 2016; Naughton 2013).
Finding 2: women are concerned that NRT can deliver an unsafe
amount of nicotine
Seven studies reported that women were worried about the
amount of nicotine delivered via NRT compared to smoking
(Borland 2013; Bowker 2016; Butterworth 2014; England 2016;
Hotham 2002; Naughton 2013; Taylor 2010). There was a common
concern that women would receive more nicotine from NRT than
they would from a cigarette, especially from higher dose patches or
when using NRT and smoking at the same time.
"The patch can give you a nicotine overdose, so it's scary, smoking
and wearing it." Pregnant smoker (England 2016)
The constant delivery of nicotine from the patch was also
problematic for some women; they believed that the increased
amount of nicotine supplied via NRT could be dangerous to their
health.
"But with the patch you would wear it all day and there's going to be
a constant kind of supply of nicotine going to the body, and I just don't
like the thought of that." Pregnant woman 14, smoker (Taylor 2010)
Finding 3: women are concerned that using NRT during
pregnancy can harm their baby
Participants most commonly expressed concerns about the
potential harms NRT could cause to their unborn baby; in 12
studies participants expressed uncertainty regarding the safety of
NRT while pregnant, which in many cases was a barrier to NRT
use (Ashwin 2010; Bauld 2017; Borland 2013; Bovill 2018; Bowker
2016; Butterworth 2014; England 2016; Glover 2012; Hotham 2002;
Naughton 2013; Radley 2013; Taylor 2010).
"All I was concerned about was um, was the nicotine being released
into your blood stream. I was worried about it a/ecting the baby." W5
(Ashwin 2010)
In four studies, some women thought there was insuGicient
evidence about the eGects of NRT on the baby for them to make a
fully informed decision (Ashwin 2010; Glover 2012; Hotham 2002;
Taylor 2010).
"I don't think there is a lot of information about NRT in pregnancy
and I don't think I had a lot of information about that, but that was
probably because it doesn't exist yet. Um, but NRT in general I think I
had plenty of information on." W8 (Ashwin 2010)
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"It seems that patches might have a more direct route to your baby
. . . I don't know how they really work. It has to go through your
bloodstream somehow . . . I don't know enough about them. . . they
[patches] are not really tested and the baby is used to me having a
cigarette and she's made it this far. I'll leave it at that." G2 (Hotham
2002)
Some women felt they would be more confident making their
decision to use NRT if more specific information on nicotine eGects
on the fetus was oGered to them (Bowker 2016; Glover 2012;
Hotham 2002; Taylor 2010).
"My main concern was obviously 'smoking passes on horrible
chemicals to the child, does this [NRT] still do that?' and [the smoking
cessation advisor] was like 'no, it's just one main one, it's just the
nicotine' so I'd have liked to have known a bit more on how that
a/ects the baby." Respondent 11; patches (Bowker 2016)
Lack of understanding about the relative safety of NRT in pregnancy
compared to smoking led to some women choosing to try quitting
'cold turkey' or continue to smoke rather than use NRT (Bovill 2018;
Bowker 2016; England 2016; Naughton 2013; Taylor 2010).
"I would rather a cigarette than wear a patch because you still
pumping the stu/ into your blood wearing a patch. . . at the end of
the day if you are going to smoke cigarettes that's not going to be any
more harmful than having a patch." 1501, smoker (Naughton 2013)
"I don't know enough about them. . . they [patches] are not really
tested and the baby is used to me having a cigarette and she's made
it this far. I'll leave it at that." G2 (Hotham 2002)
"They say the nicotine is what stunts the baby's growth and things
like that, so I think, well if I can stop smoking [without NRT], then
what's the point in me putting a patch on?" Pregnant woman 14;
smoker (Taylor 2010)
Finding 4: women believe that e-cigarettes are safer than
smoking
Women's views on the safety of e-cigarettes varied depending on
whether they concerned general use or in pregnancy. Women in five
studies indicated that they thought e-cigarettes to be less harmful
than smoking traditional cigarettes, for both the vapour and in
terms of second-hand smoke (Bauld 2017; Bowker 2018; England
2016; Fallin 2016b; Grant 2020). Study participants referred to e-
cigarettes as being 'cleaner' and 'safer' because they believed these
contained fewer chemicals than traditional cigarettes and no tar.
In some cases, e-cigarettes were perceived as a harm reduction
strategy.
"It [e-cigarette] doesn't pass on second-hand smoke, because even
if the baby was close by, which I wouldn't have a baby close by,
it wouldn't be dangerous." 19 antenatal ex-smoker and current e-
cigarette user (Bowker 2018)
"I think the idea behind it—is that because it's water vapour you're
not getting some of the tar and some of the other things you get out
of a regular cigarette." Pregnant smoker (England 2016)
"It's just vapour, like you have nothing to lose by using their product."
(Fallin 2016b)
Three of these studies also mentioned that some women feel
uncertain about e-cigarette safety due to lack of evidence on this
(Bauld 2017; Bowker 2018; Fallin 2016b).
Finding 5: women are concerned that e-cigarettes can deliver an
unsafe amount of nicotine
In two studies some women were concerned about the amount of
nicotine and the potentially harmful properties of other chemicals
delivered via the e-cigarette (Bowker 2018; England 2016). Women
were also concerned that an e-cigarette could be used for as long
as they wanted.
"Obviously with a cigarette you can only smoke it for so long till it's
finished, but with an e-cigarette you can smoke for as long as you
want to. So sometimes, I guess, I was taking in more than the usual
nicotine intake that I would have done with a cigarette." 01 antenatal
ex-smoker and ex-e-cigarette user (Bowker 2018)
On the other hand, one study suggested that women found the
opportunity to choose the concentration of nicotine in their e-liquid
beneficial (Fallin 2016b).
"Lower milligrams of nicotine is better and if you can get the ones
without nicotine in it, that's even better." (Fallin 2016b)
Finding 6: women are concerned that using e-cigarettes during
pregnancy can harm their baby
Women in three studies reported some uncertainty about the
safety of using e-cigarettes during pregnancy and believed there
was insuGicient available information about the eGects of vaping
on the baby to make an informed decision about using these in
pregnancy (Bauld 2017; Bowker 2016; Fallin 2016b). Women viewed
e-cigarettes as a new and untested product.
"I wasn't allowed anything like that during pregnancy because they
have not tested things like that properly yet." Area A, pregnant
woman 18, non-smoker (Bauld 2017)
Theme 2: concerns about addictiveness of nicotine – women's
beliefs about addictiveness of nicotine influence their use of
NRT in pregnancy
Finding 7: women report concerns that NRT is as addictive as
smoking
Four studies briefly reported women's concern about the addictive
potential of NRT (Ashwin 2010; Bowker 2016; England 2016; Taylor
2010). Data were relatively thin, however, with few participant
quotes.
Some women felt that using nicotine products of any kind
constituted 'not actually quitting' or replacing one addiction with
another (Ashwin 2010; Bowker 2016; Taylor 2010).
"Well, all they keep saying is you know it gets rid of the toxins, you still
get the nicotine but it gets rid of the toxins, this, that and the other and
it's just in that the nicotine you take it in. The nicotine itself is what
makes it addictive, so to me the more nicotine that you're taking in
anyway, the more you're going to want to smoke or you know you're
going to need that nicotine." Respondent 6; inhalator (Bowker 2016)
There was also a belief that becoming addicted to NRT would
prolong the quitting process and would give women 'something
else they would have to quit aKer quitting smoking', and therefore
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they were unwilling to start using it or tried to use it for short periods
only (Ashwin 2010; Taylor 2010).
"I didn't want to be on it too long because I was worried about
getting addicted to that. And replacing one addiction with another."
W4 (Ashwin 2010)
"That's why I decided not to do it [use NRT] personally because you're
going to give it [smoking] up, you're prolonging the process by having
the nicotine still being put into your body ... you have to believe you
can cope without." Pregnant woman 6; recent quitter (Taylor 2010)
In one study women noted that NRT might be better than e-
cigarettes with regards to weaning oG nicotine (Bowker 2018).
Theme 3: e6ectiveness of nicotine-containing products –
women's beliefs about the e6ectiveness of nicotine-containing
products influence their use in pregnancy
Eleven studies contributed data on women's views on eGectiveness
of NRT for aiding quit attempts or managing tobacco cravings or
withdrawal symptoms (Ashwin 2010; Bauld 2017; Bowker 2016;
Butterworth 2014; England 2016; Fallin 2016a; Hotham 2002;
Mantzari 2012; Pledger 2015; Radley 2013; Taylor 2010). Most
studies reported that eGectiveness beliefs were based on women's
current or past experience with NRT, but some studies also reported
eGectiveness beliefs of women whose beliefs were based on other
peoples' reports of their experiences (England 2016; Hotham 2002;
Taylor 2010). Opinions were mixed both between and within
studies.
Finding 8: past positive experiences of NRT can facilitate NRT
use in pregnancy
Women frequently expressed their opinion on eGectiveness of
NRT in terms of its ability to help them quit smoking or in
terms of helping cope with withdrawal symptoms. Women in five
studies reported that the NRT they used helped support their
quit attempt (Bauld 2017; Bowker 2016; Butterworth 2014; Pledger
2015; Taylor 2010), and one of these studies indicated that knowing
someone who found NRT eGective also improved beliefs about NRT
eGectiveness in never-users (Taylor 2010).
"I swore by those, they were really good. . . you don't even think about
a fag when you are on a patch." Area A, pregnant woman 17, non-
smoker (Bauld 2017)
"I mean if I'm stressed or anything, if I get a squirt, once I take
my squirt [description of inhalator] it's like a relief, I feel calm, I
feel relaxed and that's all it is pretty much. …..But that's how you
basically feel, you feel calmer, more relaxed." Respondent 6; inhalator
(Bowker 2016)
Finding 9: past negative experiences with NRT can be a barrier
to use of NRT in pregnancy
In seven studies, women reported a belief that NRT had not helped
them to stop or had failed to control their cigarette cravings (Bauld
2017; Bowker 2016; England 2016; Fallin 2016a; Mantzari 2012;
Pledger 2015; Taylor 2010). A number reported that consequently
they smoked occasional cigarettes to help with cravings, usually
without seeking advice from a health professional (Bowker 2016).
"I was really struggling. It [the patch] was stuck but it felt like I was
getting no nicotine. And it didn't matter how much I pu/ed on the
inhalator I was just su/ering like really bad. So I started smoking over
that weekend." Respondent 7; patches, inhalator and mouth spray
(Bowker 2016)
Additionally, one study reported that some women who struggled
with cravings independently decided to wear NRT patches for
longer than recommended to help cope with these (Bowker 2016).
In other studies, some women who had used lower dose patches
found these ineGective (Bauld 2017; Mantzari 2012).
"She did say to put them on and take them o/ before bedtime to
give you and baby a rest. I was finding I was waking up and wanting
a cigarette so I took it upon myself to leave them on for 24 hours."
Respondent 9; patches (Bowker 2016)
Women treated for opioid dependency found NRT to be less
eGective in treating their smoking addiction than medication for
opioid dependency (Fallin 2016a).
"I keep thinking to myself, I'll be able to quit if I quit the drugs [heroin]
and I had medicine to help me get o/ of drugs [MAT]. The same thing,
nicotine patch….and I still can't quit. I still have the desire to smoke."
(Fallin 2016a)
Three studies found women believed that willpower was the key
factor in any quit attempt and therefore felt that NRT was not going
to help unless they were ready to quit (Ashwin 2010; Hotham 2002;
Taylor 2010). In one, women who managed to quit attributed their
success to willpower or health professionals' support, rather than
the NRT (Ashwin 2010).
"I don't think that (gum) had anything to do with it. I think it was just
willpower and the fact that that, um, my advisor was coming to see
me as well." W9 (Ashwin 2010)
Never-users who knew of people that failed to quit on NRT had
negative beliefs about NRT eGectiveness (England 2016; Hotham
2002; Taylor 2010).
Finding 10: women present mixed views on e*ectiveness of e-
cigarettes
Four studies contributed data on women's views on eGectiveness of
e-cigarettes, although these were very sparse, with mixed opinions
reported and minimal insight into how these might aGect readiness
to use e-cigarettes (Bauld 2017; Bowker 2016; Bowker 2018; Grant
2020). One study concluded that women did not find e-cigarettes
helpful in a quit attempt (Bowker 2016), but in two others, women
perceived e-cigarettes could potentially help them to quit (Bauld
2017; Bowker 2018). An interviewee in one study reported that
while she successfully used an e-cigarette to quit before pregnancy,
she started craving regular cigarettes when pregnant and had to
supplement her e-cigarette use with smoking to manage cravings
(Grant 2020).
"I smoked and then I quit and then I, when I found out I did quit
but then I started smoking again when I was pregnant and then I
went onto those e-cig fags and then I stopped on that but now I am
pregnant again I've started having a few fags again it's like I've got
a craving for smoke or something, it's really weird, I'm not a heavy
smoker but if I am in the house I'll fancy like a little cig or something,
you know." Cat (Grant 2020)
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Theme 4: side e6ects – women's beliefs about and experiences
with side e6ects of NRT influence their use of NRT in
pregnancy
Finding 11: women who report experiencing and feeling unable
to deal with side e*ects of NRT perceive these as a barrier to NRT
use in pregnancy
Nine studies contributed data on women's experiences of side
eGects when using NRT (Ashwin 2010; Bauld 2017; Bovill 2018;
Bowker 2016; Butterworth 2014; England 2016; Mantzari 2012;
Pledger 2015; Taylor 2010).
The side eGects of NRT are well documented (Mills 2010); here
we focus on how experiencing these side eGects had aGected
women's continued use of NRT once these had been encountered.
Some studies noted that women were delaying the next dose or
discontinuing use of their oral NRT when experiencing unpleasant
eGects, especially when they felt it exacerbated their morning
sickness (Bowker 2016; Butterworth 2014; Mantzari 2012; Taylor
2010). Overall, women tended to discontinue or use NRT in non-
standard ways without seeking advice or support from health
professionals. One respondent noted, "It would have been nice to
have a heads up [from health professionals] about it that it makes
you feel sick" Respondent 5; gum (Bowker 2016), as it could prepare
women to deal with side eGects more eGectively.
"Yeah, totally delayed cos I keep saying oh I don't want to taste it yet,
I'll give it another 10 minutes you know or I'll give it a bit longer. It is
delaying it cos you think I'm not looking forward to the taste of it so
I'll just wait a bit longer." Respondent 3; inhalator (Bowker 2016)
"I was just more worried about the side e/ects obviously because I'm
quite early on in pregnancy, and especially with morning sickness
anyway, I didn't know that it [NRT] would cause – obviously [it] made
me feel more nauseous and [I] vomited quite a few times when I had
the gum. So just would have been nice to have a heads up about it
that it makes you feel sick" Respondent 5; gum (Bowker 2016)
Commonly experienced side eGects associated with patches
included skin irritation or burning (Bauld 2017; Bowker 2016;
England 2016; Mantzari 2012; Taylor 2010); strange dreams (Ashwin
2010; England 2016; Pledger 2015); and headaches, hallucinations
and paranoia (Taylor 2010). Women also oKen reported issues with
patches leaving marks or adhering poorly to the skin (Ashwin 2010;
Fallin 2016b; Pledger 2015). NRT patch side eGects were considered
diGicult to manage and led some women to discontinue these early
(Bauld 2017; Bowker 2016; Mantzari 2012; Taylor 2010).
Some women perceived NRT gum, inhalators, and microtabs as
unpleasant tasting, and in a few they caused mouth irritation or
exacerbated nausea and/or vomiting, which led to women delaying
doses or discontinuing use (Bovill 2018; Bowker 2016; Butterworth
2014; England 2016; Mantzari 2012; Taylor 2010). One study noted
that women developed strategies to help them manage these,
including taking mints or sipping water (Bowker 2016).
Theme 5: influence of others – women's readiness to use
nicotine-containing products in pregnancy is influenced by the
perceived views of and support from other people
In 14 studies, the influence of health professionals, but also family
and friends, was found to be an important factor aGecting women's
views on NRT and on their readiness to use it (Ashwin 2010; Bauld
2017; Borland 2013; Bovill 2018; Bowker 2016; Butterworth 2014;
Gamble 2015; Glover 2012; Hauck 2013; Herbec 2014; Mantzari
2012; Pledger 2015; Radley 2013; Taylor 2010). Four studies focusing
on e-cigarettes also contributed data to this theme (Bauld 2017;
Bowker 2018; Fallin 2016b; Grant 2020).
Finding 12: women who report receiving clear and consistent
reassurance from health professionals about NRT safety in
pregnancy feel this can facilitate NRT use
Health professionals were perceived as a key source of information
and advice on safety and use of NRT, and women reported
generally following their advice. Five studies reported that receiving
reassurance about NRT safety in pregnancy from a health
professional (e.g. midwife or a stop smoking practitioner) was
the key factor that helped alleviate safety concerns, improve
acceptability of NRT and/or make women feel more at ease to
initiate NRT use in pregnancy (Ashwin 2010; Bauld 2017; Bowker
2016; Gamble 2015; Taylor 2010).
"No, I mean I double checked that everything was okay for me to use it
while I was pregnant. Yeah. So I thought it didn't concern me, because
I had been told it was safe to use." W9 (Ashwin 2010)
"I made doubly sure. I was like 'they are safe?' and she goes,
'I wouldn't be prescribing them to you if they weren't safe in
pregnancy.' " Area B, pregnant woman 16, smoker (Bauld 2017)
Two studies reported that never-users also felt they would try NRT
if they received suGicient reassurance about safety from a health
professional (Hotham 2002; Taylor 2010).
"I would try, as long as you could convince me it was safe. Have a
discussion on it - how it a/ects the baby - what patches do - the
positives and negatives about them. . ." G1 (Hotham 2002)
Finding 13: women who report experiencing lack of support
towards NRT use from health professionals are reluctant to use
NRT in pregnancy
Five studies reported instances in which women felt unconvinced
about safety or were discouraged from NRT use in pregnancy
as a result of misinformation, misunderstanding or a health
professional's active discouragement/apparent lack of confidence
in advising on NRT use in pregnancy (Borland 2013; Bowker 2016;
Gamble 2015; Hotham 2002; Mantzari 2012). Sometimes the advice
women received did not adequately address their specific concerns
(Bowker 2016).
"I said to her, erm, er, 'yeah about me being pregnant and still
carrying the lozenges', she's like 'Yeah?' I said 'I've got patches at
home can I still use them, like can I start on them again rather than
give me more, they're from last year they're still in date though?' And
she said, 'I've never dealt with a pregnant woman before.' Participant
34, control group (Mantzari 2012)
"They told me here not to do that and they wouldn't give me the
patch because I was pregnant." Postpartum woman, Central region
(Borland 2013)
"I can remember the conversation we had about it and [the smoking
cessation advisor] was letting me know where I can put [the patches]
and whatnot, but to myself I just thought no, that's just a bit too –
you know you sit there thinking about it. I don't know, it's weird, I just
think it's too close to the baby to be having all that nicotine going in."
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Respondent 10; patches. This participant was not convinced about
the safety of using her nicotine patch even aKer being advised
about it; she decided to revert back to smoking as she felt that the
harms of using her patch on her lower back would be too dangerous
for her baby (Bowker 2016).
Seven studies suggested that women felt dissatisfied with
the support and advice from health professionals. Receiving
inadequate support and advice about NRT in pregnancy was
perceived as a barrier to NRT use and smoking cessation in
general (Borland 2013; Bovill 2018; Bowker 2016; Gamble 2015;
Glover 2012; Hauck 2013; Mantzari 2012). Five studies with
predominantly Aboriginal, Torres Strait Island and Maori women
presented negative experiences of health professional counselling,
including perceived lack of support, inconsistent messages about
safety and lack of expertise with regards to NRT and smoking
cessation in general aGecting these communities (Borland 2013;
Bovill 2018; Gamble 2015; Glover 2012; Hauck 2013). These studies
suggested that misinformation or hesitation about recommending
NRT hindered their quit attempts by confusing women about
whether NRT is safe or permitted in pregnancy. Similar views
were presented in some studies with predominantly white British
women (Bowker 2016; Mantzari 2012), but in these studies, women
also reported many positive experiences with smoking cessation
support (Ashwin 2010; Bauld 2017; Bowker 2016; Butterworth
2014).
"They say 'do you want to quit smoking?' and you tell them you do
but it's like 'we'll encourage you to but we're not going to properly
support you to do it'." W16 (Bovill 2018)
"She gave me the patch where I wanted the highest patch that I could
have because I've been smoking 24/7, they actually told me the most
I could have was a 20 mg patch, which now I've been told by the
midwife that's not true . . . The patch didn't seem to be working. And
then when I told my midwife it didn't work and she said it was, erm,
that I could have more than a 20 mg patch. . . I wouldn't be smoking
now if the pharmacist had given me the right amount". Participant
09, control group (Mantzari 2012)
Five studies reported that women specifically expressed the need
for more support and guidance on NRT use (Bovill 2018; Bowker
2016; Herbec 2014; Pledger 2015; Taylor 2010).
Finding 14: women feel discouraged from using NRT in
pregnancy by the perceived views and experiences of other
people (non-health professionals)
Four studies contributed data on the perceived influence of family
and friends on attitudes towards NRT or readiness to use NRT in
pregnancy (Bovill 2018; England 2016; Hotham 2002; Taylor 2010).
In most cases, reports from women suggested that the experiences
of family and friends served as a barrier to using NRT. In some
cases anecdotal accounts of a friend or family member having a
bad experience with NRT, such as experiencing unpleasant side
eGects, tended to put women oG using it in their own quit attempt
(England 2016; Hotham 2002; Taylor 2010). In other cases (Taylor
2010), women felt actively discouraged from NRT use by their family
or by the fact that they did not know many people who had used
NRT (Bovill 2018).
"Everyone I know that has quit smoking has just gone cold turkey, like
they haven't used anything." W2 (Bovill 2018)
"[I wouldn't want to use NRT] from stories that I've heard o/ other
people nightmares and hot sweats and things like that." Pregnant
woman 1; recent quitter (Taylor 2010)
Only one study reported that women felt their family and friends
would support their use of NRT to quit in pregnancy (Taylor 2010).
"Yes, my family would approve [of me using NRT], definitely."
Pregnant woman 12; recent quitter (Taylor 2010)
Some women in this study also reported feeling embarrassed
and judged to be seen using NRT (particularly inhalators) while
pregnant, as much as they would if they smoked in public. This
feeling of being judged and self-consciousness sometimes served
as a barrier to using NRT in public (Taylor 2010).
"They see you walking street and you've got that thing in your mouth
[inhalator], they'll think, 'hold on a minute, that's not good, she's not
allowed to do that, you'd proper get some weird looks... I don't care
what people think." Pregnant woman 4; smoker (Taylor 2010)
Finding 15: women's readiness to use e-cigarettes in pregnancy
is influenced by the advice they report receiving from their
health professionals
In four studies most women reported that their health professionals
did not endorse the use of e-cigarettes in pregnancy (Bauld 2017;
Bovill 2018; Fallin 2016b; Grant 2020). Media reports recalled by
the women also tended to be negative, in particular highlighting
product malfunctions and health scares, and women did not report
verifying this information with their health professionals (Bowker
2018; Fallin 2016b).
Lack of information about safety and discouragement from health
professionals oKen led to pregnant women's reluctance to try e-
cigarettes or a desire to stop using them (Bauld 2017; Bowker 2016;
Bowker 2018).
"[I tried] an e-cig[arette] which was really good. . . It's good to have
this you know the smoke coming out and going through all the
motions, but I wasn't allowed anything like that during pregnancy
because they have not tested things like that properly yet." Area A,
pregnant woman 18, non-smoker (Bauld 2017)
Bowker 2018 reported that women felt more confident using NRT
than e-cigarettes because they believed NRT was recommended by
health professionals; women in this study were reluctant to start
using e-cigarettes until safety of the product was established and
clearly communicated.
"Yeah and I think obviously if there was some sort of government
stamp on it or you know, you don't buy toys without having
something, you don't buy anything without, even the bad stu/ you
know, you buy a packet of cigarettes and the government have put
what it can do to you on it, with all the pictures. Whereas there's
nothing, is there? There's no nothing, no good, no bad, no nothing."
15 antenatal smoker and never user (Bowker 2018)
On the other hand, some pregnant women decided to continue
using e-cigarettes (Bowker 2016), or they showed interest in
using them despite discussing 'unknown risks' with their health
professionals (Bauld 2017). One participant decided to continue
using e-cigarettes based on her own 'online research', which
satisfied her that vaping was safer than smoking (Grant 2020).
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"The doctors and the health visitors all say: 'Are you going to cut
down?' And I say: 'No, I don't think it's harming my child' so I am
happy to stay on them and that's it really . . . it hasn't got any of the
harmful chemicals like tar and all you know. . . it's my decision and
I'm happy with this like you know?" Becky (Grant 2020)
Two studies reported that some women were encouraged to use e-
cigarettes by their health professional (Bowker 2018; Fallin 2016b).
"And then I completely just quit and picked up the e-cig and worked
with it while I was kind of pregnant but I was kind of scared but I
talked to my doctor about it and they said it was fine you know, so."
(Fallin 2016b)
Overall, there were mixed reports about women's experiences
of health professionals' stance on e-cigarette safety, and, apart
from a small number of participants in three studies (Bauld 2017;
Bowker 2018; Grant 2020), women tended to consider their health
professionals' advice when making a decision to use e-cigarettes in
pregnancy.
Finding 16: women's readiness to use e-cigarettes in pregnancy
is influenced by other people (non-health professionals)
There was limited evidence about the role of family and friends
in the studies, but two studies mentioned that family and friends
encouraged pregnant women to use e-cigarettes to quit smoking
(Bauld 2017; Bowker 2018).
"They [family] were a lot happier about me using that [e-cigarette]
than obviously smoking. My Mum actually bought me the e-cigarette
and she never ever bought me cigarettes in my life." 08 antenatal
smoker and current e-cigarette user (Bowker 2018)
In addition, two studies also noted that women felt judged by other
members of the public when using e-cigarettes, which reduced
their willingness to use e-cigarettes in public places (Bowker
2018; Grant 2020). Some women said they felt embarrassed and
uncomfortable to be seen using an e-cigarette while pregnant or
out with children, similar to when smoking.
"And I smoke my e-cig and some people might not, not that that
bothers me at all, but they might look at me and like judge but it
doesn't bother me but it's still a factor in the pregnancy." Becky (Grant
2020)
Theme 6: characteristics of nicotine-containing products can
influence women's readiness to use them in pregnancy
Finding 17: perceived characteristics of the NRT product, such as
cost, convenience and ability to mimic a cigarette, can influence
uptake and continuous use of NRT in pregnancy
Eleven studies contributed data to how the characteristics of
NRT products can influence women's views and readiness to use
them (Ashwin 2010; Bauld 2017; Bowker 2016; (removed Bowker
2018) Butterworth 2014; England 2016; Fallin 2016a; Fallin 2016b;
Hotham 2002; Pledger 2015; Radley 2013; Taylor 2010). The key
characteristics that influenced women's attitudes towards NRT use
were attractiveness, convenience of use, cost, and behavioural
substitution.
Some women found NRT fairly discreet and easy to use (Ashwin
2010; Bowker 2016; Butterworth 2014; Taylor 2010). Overall, NRT,
particularly inhalators and patches, was viewed as unattractive,
boring, medicinal and hard to hide. Some women felt that patches
did not adhere to skin properly and leK unattractive marks (Ashwin
2010; Butterworth 2014; England 2016; Fallin 2016b; Pledger 2015;
Taylor 2010). One study mentioned that the appearance was
one of the main reasons for discontinuing the use of inhalator
(Butterworth 2014).
In one Australian study where women had to pay for NRT, some
perceived the cost to be prohibitive (Hotham 2002). In two UK
studies, authors reported that women were unaware that NRT
would be provided free of charge (Bauld 2017; Taylor 2010).
Women oKen chose their product based on its ability to mimic
the traditional cigarette; some women found that inhalators
helped manage the behavioural aspects of their addiction, such
as the hand-to-mouth action (Ashwin 2010; Bauld 2017; Bowker
2016; Taylor 2010). Some also felt that inhalators allowed them
to continue socialising with friends who smoked (Bowker 2016;
Butterworth 2014; Taylor 2010).
"I don't know what to do with my hands when I'm not smoking – so
that's why I used the inhaler because it's something in my hands and
it can help – feels like I'm smoking a fag [cigarette] kind of thing."
Respondent 2; inhalator (Bowker 2016)
Patches were perceived as least like cigarettes. This was
problematic for some women (England 2016; Fallin 2016a; Hotham
2002; Taylor 2010), but beneficial to others, as they did not remind
them of cigarettes (Bowker 2016).
"The hands thing. You're going to the pub. You're still getting your
nicotine, but with your co/ee? It's the hands." G3; about patches
(Hotham 2002)
Finding 18: perceived characteristics of e-cigarettes, such as
cost, convenience and ability to mimic a cigarette, can influence
uptake and continuous use of e-cigarettes in pregnancy
Five studies contributed data on how women perceived the
characteristics of e-cigarettes aGected their readiness to use
them (Bauld 2017; Bowker 2018; Butterworth 2014; England 2016;
Fallin 2016b). The appearance of e-cigarettes was oKen viewed
positively by the women, with some describing them as 'cool' or
'cute' (England 2016). They especially liked the smaller, slicker,
more convenient products (Bowker 2018). They also found the
selection of flavours particularly exciting and satisfactory (England
2016; Fallin 2016b).
"Today, I feel like a menthol, tomorrow I'll feel like strawberry, the
next day I feel like unicorn." (Fallin 2016b)
Women disliked having to refill e-cigarettes where the fluid was sold
separately and required frequent charging, especially as chargers
could be diGicult to replace if lost (Bauld 2017; Fallin 2016b).
Cost influenced women's decisions to use e-cigarettes. E-cigarettes
were not free of charge to any of the women who participated
in studies. Some women believed e-cigarettes were good value
(Bowker 2018; England 2016), while others felt they were more
expensive than smoking (Bauld 2017; Butterworth 2014).
"I had one of them e-cig[arette] things you know the ones with the oil,
and it lasted 3 weeks and then I got rid of it because it was rubbish to
be fair. It was, you had to charge it all the time and then you had to
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buy the fluid and then it just ended up costing like the same amount
as regular cigarettes. It was – there was no point." Area B, pregnant
woman 17, smoker (Bauld 2017)
E-cigarettes were believed to provide good behavioural
substitution for smoking traditional cigarettes (Bauld 2017; Bowker
2016; Bowker 2018; Butterworth 2014; England 2016; Fallin 2016b).
"[I tried] an e-cig[arette] which was really good. . . It's good to have
this you know the smoke coming out and going through all the
motions." (Bauld 2017)
Some women, however, found these products not as satisfying as
smoking, which was a source of frustration, while others found it
too much like the cigarette or a cue to smoking (Bowker 2018; Fallin
2016b).
"I think not smoking at all was less frustrating than trying to get the
satisfaction of a real cigarette from an e-cigarette." (Fallin 2016b)
"One thing I missed when I have quit smoking is inhaling the smoke,
so when I used an e-cigarette obviously you've got that kind of
experience of inhaling the vapour. It was too much, it was too
similar to having a cigarette, so it made me miss it even more." 01
antenatal ex-smoker and ex-e-cigarette user (Bowker 2018)
Analytical themes
We identified three analytical themes representing the key
determinants explaining uptake of and adherence to NRT and
e-cigarettes; each potentially acted as a barrier or facilitator to
use. Similar descriptive themes emerged from NRT and e-cigarette
studies, but some issues only appeared to relate to NRT. Overall,
we felt that the determinants of e-cigarette and NRT use were
relatively similar, and that even more similarities, and perhaps
some diGerences, might have been apparent had there been more
data on e-cigarettes.
1. Women consider health professionals' advice when making
decisions about NRT or e-cigarette use in pregnancy
Findings (F) contributing to this theme: F12 (moderate confidence),
F13 (high confidence), F15 (high confidence).
When pregnant women perceive that health professionals endorse
NRT or e-cigarettes as smoking cessation aids, they feel more
confident about using them. Conversely, when health professionals
provide inconsistent or unclear information about safety or
appropriateness of using these products, women can be less willing
to use them.
2. Women see protecting their unborn baby as a priority
Findings contributing to this theme: F1 (moderate confidence),
F2 (moderate confidence), F3 (high confidence), F4 (moderate
confidence), F5 (low confidence), F6 (moderate confidence), F7
(moderate confidence).
The degree to which women perceive NRT and e-cigarettes to be
acceptable and safe cessation aids influences how much they use
them. Women who believed that these were safer than smoking
were more willing to use them in quit attempts. However, where
women perceived that NRT or e-cigarettes were at least as harmful
as smoking, their concern for the eGect these might have on their
unborn babies hindered their acceptance of them as quit aids
during pregnancy. Some women lacked understanding of which
tobacco smoke components cause most harm, with many believing
this to be nicotine. Many were concerned about the possible
addictiveness of nicotine and worried that NRT and e-cigarettes
could deliver higher, and therefore less safe, nicotine doses than
cigarettes.
Nicotine-related fears can deter women from using NRT or e-
cigarettes. Such fears may stem from the perceived lack of evidence
regarding safety of NRT and e-cigarettes and/or from negative
opinions about NRT and e-cigarettes expressed by family and
friends, and sometimes by health professionals. The belief that
there is insuGicient safety evidence was particularly apparent in
relation to e-cigarettes. However, women in some NRT studies,
including recent ones, expressed fears about nicotine and hence
about NRT safety, despite NRT being increasingly recommended
internationally as a cessation aid in pregnancy (ACOG 2017; Bar-
Zeev 2018; CAN-ADAPTT 2011; NZ Ministry of Health 2014; NICE
2010).
3. Women's previous experience using NRT influences their
motivation to use NRT in pregnancy
Findings contributing to this theme: F8 (moderate confidence),
F9 (moderate confidence), F10 (low confidence), F11 (high
confidence), F14 (high confidence), F16 (moderate confidence), F17
(moderate confidence), F18 (moderate confidence).
Past positive experiences with NRT, or those of their family and
friends, can influence pregnant women's beliefs about likely
eGectiveness of NRT, encouraging them to try it. Conversely,
previous negative experiences of using NRT in unsuccessful quit
attempts, ineGective management of withdrawal symptoms or
experience of unpleasant side eGects, or family and friends' reports
of similar issues can discourage pregnant women from trying NRT.
AKer initiating NRT, there are many reasons why women might find
it unhelpful and discontinue it early. For example, they might use
insuGicient NRT to ameliorate nicotine cravings due to concerns
about nicotine; when they subsequently continue to experience
cravings, women may believe NRT is not helping them. For e-
cigarettes, there is less evidence on how past experience influences
future use; available data suggests a similar relationship to that for
NRT, but more research could confirm or refute this.
Integrating the findings from this synthesis with the
findings of the relevant Cochrane e6ectiveness review
Here we consider how findings from this qualitative evidence
synthesis (QES) might relate to those from a Cochrane Review
that investigated eGectiveness of pharmacological treatments for
smoking cessation in pregnancy (Coleman 2015, updated Claire
2020). The following issues from that review are relevant here.
• There were no completed trials of e-cigarettes in pregnancy.
• All participants in review trials agreed to being randomly
allocated to NRT or control (placebo or behavioural support
only), which implies that they did not hold strong negative
beliefs about NRT.
• Descriptions of counselling about NRT use were very brief.
• NRT was borderline eGective compared to control.
• Study design was the only factor found to influence NRT
eGectiveness estimates. Trials that were not placebo-controlled
produced higher eGectiveness estimates than those with
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placebo control; review authors concluded that this was due to
bias.
• Where studies reported adherence to NRT, this was universally
low. However, as adherence reporting was inconsistent, intra-
study comparisons were not possible.
As there were no e-cigarette trials, this section only relates QES
findings on NRT to the Cochrane eGectiveness review.
With respect to the determinants of women's decisions to start
NRT, we consider that findings from the qualitative studies in
this QES have limited transferability to the context of RCTs. All
women enrolled in RCTs included in Coleman 2015 (updated
Claire 2020) had to understand standardised information on NRT,
received counselling about NRT from trained health professionals
and, following this process, agree to use NRT, placebo or to only
receive behavioural support. Conversely, women recruited to QES
qualitative studies are less likely to have received any formal advice
on NRT, and information from health professionals' may have been
less comprehensive or consistent than that given in RCTs. In some
QES studies, women reported inadequate or inaccurate advice
from health professionals, and some health professionals were
negative about NRT. While women in trials may have had similar
previous experiences, any negative impressions of NRT as a result
would have likely been addressed when they enrolled in the trial.
In this QES, the influence of health professionals' advice was a key
determinant of women's decisions about NRT use, so we feel the
diGerences outlined above are important and that QES studies'
findings are not directly transferable to trial participants' decisions
around the use of NRT.
Although we do not think it is appropriate to equate the initiation
of NRT in an RCT versus routine health care, we consider
that QES findings are relevant to why women decide to carry
on or stop using this aKer starting NRT. In smoking cessation
RCTs, participants receive most behavioural support in initial
consultations. AKerward, trial participants who use NRT oKen have
relatively little contact with health professionals, so women are
likely to make decisions on continuing or stopping NRT without
further professional advice; this is similar to the conditions of
routine health care (Bowker 2016). Hence, we believe that QES
findings are much more transferable to, and likely to help explain,
women's adherence to NRT in both routine care and RCTs, and
we propose using QES findings to help understand why adherence
to NRT in eGectiveness review trials was so low (Coleman 2015,
updated Claire 2020). This is an important issue because when
pregnant women adhere more strongly to NRT, they have a
better chance of becoming abstinent (Raupach 2014). To facilitate
investigation of how QES findings might explain trial participants'
adherence to NRT, we created a matrix showing the extent to which
key QES findings are represented within interventions used for
each trial in the eGectiveness review (see Appendix 6). Across most
eGectiveness review trials, this demonstrates the following key
issues.
• All eGectiveness review trials included behavioural support, but
trial reports gave little detail about the information on NRT
included in this support (Coleman 2015, updated Claire 2020).
• Initial and follow-up counselling in trials was usually delivered
by the same health professionals, so it is likely to have been
consistent.
• Few trials oGered participants a choice of NRT types.
QES findings show that pregnant women value health
professionals' clear advice about NRT and are more likely to
follow this when it addresses any concerns they may have about
nicotine use in pregnancy. It is unclear if support delivered in the
eGectiveness review trials included this specific advice, as details
provided in trial reports were very scanty. However, as most studies
finished recruiting over nine years ago and there was only limited
literature on NRT safety then, this seems unlikely (Coleman 2015,
updated Claire 2020). Another issue, which is unclear from trial
descriptions, is the degree to which information about NRT might
have been delivered consistently. Again, QES findings suggest that
this is important to pregnant women. In most of the RCTs included
in the eGectiveness reviews (Coleman 2015, updated Claire 2020),
both initial and follow-up behavioural support was delivered by
a single team of smoking cessation-trained health professionals.
Although it is not explicitly stated or reported, it is highly likely that
these teams delivered consistent messages about NRT. However,
in two larger trials, routine healthcare staG provided follow-up
counselling, whereas trial staG provided initial support; in these
RCTs, messages given about NRT may have been less consistent
(Berlin 2014; Coleman 2012). Appendix 6 also demonstrates the
limited extent to which trial participants had a choice of NRT
product (e.g. patch versus inhalator); the QES found that women
reported product choice as being potentially influential in their
decisions to start and subsequently continue using NRT. Only Pollak
2007 oGered women a choice of NRT types (i.e. gum, lozenge, or
patch). Other RCTs restricted women to only one NRT type, and
although four trials oGered varied NRT strengths, only one type of
NRT was used in each study, and NRT selection was guided by the
severity of women's nicotine dependence so they could not actually
choose their NRT (Berlin 2014; El-Mohandes 2013; Oncken 2019;
Pollak 2007).
QES findings suggest that to maximise participants' adherence to
NRT, and potentially their chances of stopping smoking, future
trials of NRT in pregnancy should develop interventions that
increase participants' chances of receiving consistent, positive
advice on NRT safety and which counter any inaccurate beliefs
about nicotine or NRT. Additionally, researchers designing trials
should consider oGering participants a choice of NRT products.
D I S C U S S I O N
Summary of main findings
This review included 21 studies that took place in five developed
countries, predominantly the UK, followed by the USA, Australia,
New Zealand, and Canada. We identified six descriptive themes and
18 individual findings situated within those themes, from which
we developed three overarching analytical themes, representing
the key determinants to uptake and adherence to NRT and/or e-
cigarettes in pregnancy. These analytical themes are related to
the advice from health professionals on NRT or e-cigarette use
in pregnancy, women's desire to protect their unborn baby from
harm, and the role of past experiences with NRT on motivation to
use it in pregnancy. Each of these determinants can either hinder
or facilitate uptake and adherence to these products, depending
on women's individual experiences. Women who perceive that the
advice and support from health professionals endorses NRT or e-
cigarette use in pregnancy, who believe that NRT or e-cigarettes
are less harmful for their developing baby than smoking, who
have successfully used these products in the past, or who have
received positive messages from peers about these, are likely to
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have more positive views on using NRT or e-cigarettes in pregnancy.
Conversely, women who have opposite beliefs and experiences are
less likely to consider using NRT or e-cigarettes in pregnancy or are
more likely to discontinue using them.
Summary of integrating the findings from this synthesis
with the findings from Cochrane e6ectiveness review
The contexts of included studies in the QES and in Coleman 2015
(updated Claire 2020) were not suGiciently similar to fully integrate
the findings. QES findings are more relevant to RCT participants'
adherence with NRT once this has been initiated than to RCT
participants' decisions on whether to start using NRT. Although
adherence with NRT is associated with cessation in pregnant
women who are trying to stop smoking (Raupach 2014), the trials
included in the eGectiveness review did not consistently or clearly
report NRT adherence outcomes, so we have not attempted to
relate QES findings to these. Instead, we have investigated the
extent to which RCTs reported using interventions, which were
consistent with the key qualitative issues experienced by women in
relation to NRT use in pregnancy. We suggest that future RCTs might
encourage women's adherence to NRT by providing consistent and
clear advice on NRT, which addresses any fears about nicotine use
in pregnancy and oGering a choice of NRT types.
Overall completeness and applicability of the evidence
Populations explored
All studies involved pregnant women who had experience smoking
during pregnancy. Not all participants had experience using NRT
or e-cigarettes, so some studies provided insight into how women
who smoked, but had not used NRT or e-cigarettes, perceived these.
Most studies did not mention the socioeconomic characteristics
of study participants; however, when reported, participants were
described as coming from disadvantaged backgrounds, which
is consistent with smoking during pregnancy being strongly
associated with maternal deprivation.
Geographical context
All identified studies were conducted in high-income,
predominantly English-speaking countries, and there are gaps in
perspectives of women living in low- and middle-income countries.
Rates of smoking in pregnancy were around 10% in the included
countries (Bar-Zeev 2018; Drake 2018; Lange 2018; NHS Digital
2019) which is higher than global prevalence of 1.7% (95% CI 0.0
to 4.5) (Lange 2018), so understanding barriers to using smoking
cessation or harm reduction aids such as NRT and e-cigarettes in
this context is important. All countries where studies took place
had guidelines recommending use of NRT by pregnant women who
were unable to quit without pharmacological support. However, for
e-cigarettes they had environments of varying permissiveness. For
example, UK health experts recommend that health professionals
should support women who wish to use e-cigarettes to quit
smoking, especially where other methods have failed (Smoking in
Pregnancy Challenge Group 2019), while in some places, such as
New South Wales (Australia), nicotine-containing e-cigarettes were
illegal (NSW Government 2019). Studies investigating e-cigarette
use were all set in either the UK or USA.
Time of data collection
NRT studies took place between 2002 and 2018, with most
completed within the last five years of this period. These oGer
contemporary evidence whilst also providing an understanding of
how views on NRT might have changed as the evidence base for
using this in pregnancy has grown. For example, studies conducted
before 2010 cited the lack of evidence for the safety of NRT in
pregnancy as a barrier to NRT use more forcefully. Compared to
NRT, e-cigarettes have been brought to market more recently, so
studies included in the QES were also very recent and revealed
that women's views on using e-cigarettes were less consistent, with
much more uncertainty about safety.
Confidence in the findings
We used GRADE-CERQual to assess confidence in findings. Of the 11
findings related to NRT, we had high confidence in 4 and moderate
confidence in 7. Of the seven findings related to e-cigarettes, one
was of high confidence, four of moderate confidence, and two
of low confidence. Lower confidence in e-cigarette findings was
attributable to there being fewer studies and data. When studies
contributing to a finding came from only one country or from a
few very similar countries, we downgraded findings for relevance
issues. We most frequently downgraded findings for adequacy
when few studies contributed to the finding or those that did
contributed only small amounts of data. We deemed the overall
quality of the included studies acceptable, and while we detected
some methodological issues, such as insuGicient reporting of data
collection or data analysis, we felt that these were rarely severe
enough to significantly aGect confidence in findings. Consequently,
we noted only minor/moderate concerns due to methodological
issues. We noted issues with coherence when there were opposing
cases within a theme; these were usually minor.
Agreements and disagreements with other studies or
reviews
To our knowledge, there are no qualitative systematic reviews
investigating determinants of NRT and e-cigarette uptake and
use in pregnancy; however, there are some similarities between
our study and others. A qualitative systematic review including
38 studies provided insights into the determinants of smoking
cessation in pregnant women, and some findings are similar
(Flemming 2015). For example, the authors of that review also
found that health professionals' advice could be perceived as a
barrier or facilitator to successful cessation in pregnancy. They
noted that pregnant women perceived consistently supportive
interactions with their health professionals to be a facilitator to
smoking cessation and that negative or ambivalent attitudes, half-
hearted support, and insuGicient practical help served as barriers
to successful quit attempts. Similar to QES findings, women in
this review also reported their desire to protect their baby as a
motivator to change their smoking behaviour (Flemming 2015).
Another qualitative systematic review investigated the barriers
and facilitators to delivering eGective smoking advice from health
professionals' perspective (Flemming 2016). Health professionals
(predominantly midwives, health visitors and obstetricians)
recognised that helping pregnant women quit smoking was a
key part of their role. However, they also believed that their
wishes to maintain positive relationships with women could make
this task diGicult. This and other barriers could lead to health
professionals addressing women's smoking inconsistently or with
mixed messages, such as advising women to cut down rather
than stop smoking completely. Women's desire to protect their
babies was also an identified facilitator to delivering support;
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health professionals felt more confident when delivering smoking
cessation messages that included the benefits of quitting for the
baby.
A recent qualitative study in 26 UK health professionals who
deliver smoking cessation in pregnancy focused on how health
professionals' believe their support and advice about using
NRT can influence pregnant women's use of this (Thomson
2019). A reported barrier to women's NRT use was women
receiving misinformation about NRT safety or appropriateness
from friends, family, and health professionals. Similar to findings
from this QES, participants also noted that pregnant women's past
negative experiences with NRT could deter them from using this.
Professionals reported a belief that when women overestimated
the eGects of NRT and underestimated the importance of willpower,
their quit attempts were more likely to fail.
There was only sparse literature on the determinants of e-cigarette
use in pregnancy, presumably because these are relatively new
products. There are no published eGectiveness trials of e-cigarettes
in pregnancy, although one is underway (Hajek 2019b). One non-
systematic review of qualitative and quantitative studies from the
USA investigating women's views on e-cigarette use in pregnancy
included seven studies (McCubbin 2017): four qualitative (two
included in this QES) and three cross-sectional surveys. The
authors concluded that while participants believed e-cigarettes
were generally safer than smoking, they were less certain about
their safety in pregnancy, which echoes findings of this QES. The
authors noted the scarcity of the evidence and highlighted the need
for further research in this field.
Limitations of the qualitative evidence findings
Most studies contributed few relevant data to the findings of this
review. Data from primary studies were relatively limited, with few
studies contributing rich data to help answer study questions and
some only contributing very small amounts. Very few studies of
either NRT or e-cigarettes specifically investigated determinants
of use. Furthermore, most did not state a theoretical perspective,
and findings were mostly presented at the manifest level of the
data. This made it challenging to move beyond primary studies'
findings, so analytical themes remain close to descriptive ones.
Most evidence came from UK-based studies, and two studies from
the USA and Australia substantially supported their findings. Few
studies reported findings on determinants of e-cigarette use, and
therefore some identified determinants of NRT use (e.g. beliefs
about addictiveness or side eGects) were not found within the
available data to apply to e-cigarettes. It is possible that with
more studies focusing specifically on determinants of NRT or
e-cigarette use in pregnancy, additional determinants could be
identified. Furthermore, the available evidence was insuGicient to
detect all diGerences in determinants of NRT and e-cigarette use.
Undescribed diGerences may exist due to diverse ways of obtaining
and/or accessing NRT and e-cigarettes, as well as varying social
and cultural perceptions of these products. For example, in the UK,
unusually, e-cigarette use is encouraged in non-pregnant people
for harm reduction, but in pregnancy it is only encouraged to help
women stop smoking when they cannot do so using other means
(Smoking in Pregnancy Challenge Group 2019). In some other
countries, for example Canada and Australia, nicotine-containing
e-cigarettes are banned or restricted (Yong 2017). This division
within the public health community regarding views on safety of e-
cigarettes as nicotine replacement/harm reduction products versus
a product that may be harmful and addictive in its own right, may
further contribute to the scarcity of the evidence base.
The included studies had some methodological limitations. Most
did not use a theoretical perspective to guide the data collection
and analysis, and findings were typically presented at the
manifest level of the data. We also noted some issues with
reporting of researchers' reflexivity, data collection, analysis, and
sample characteristics. Overall, studies were of acceptable quality;
however, these methodological issues could potentially pose a
threat to the reliability and validity of the findings of included
studies (Morse 2002).
We also note limitations relating to quality assessment in
reviews of qualitative studies. There is still some controversy
surrounding quality assessment tools for qualitative studies, and
the methodology is developing (Noyes 2018; Santiago-Delefosse
2016). The current guidance suggests that scores for quality
assessment in qualitative studies are meaningless (Munthe-Kaas
2018; Noyes 2018). Instead, review authors should report the
methodological limitations of primary studies with an indication
how these limitations can impact the interpretation of findings.
A U T H O R S '   C O N C L U S I O N S
Implications for practice
Clear, consistent messages from health professionals about the
relative safety and eGectiveness of NRT or e-cigarettes compared to
smoking could potentially improve women's uptake and adherence
to these products and may help some women to stop smoking.
Furthermore, information on the most eGective ways of using these
products could also potentially improve adherence and increase
smoking cessation.
Implications for further research
To better understand pregnant women's decisions to use and
adhere to NRT and e-cigarettes, future qualitative studies that
specifically address determinants of use are needed. To understand
more about pregnant trial participant's adherence to NRT and
e-cigarettes, trials should be accompanied by qualitative studies
that aim to understand factors influencing adherence to NRT and/
or e-cigarettes. Interview studies, focus groups, and case studies
could help shed light on this issue. Furthermore, a strong evidence
base for the safety of NRT and/or e-cigarettes in pregnancy could
enable health professionals to more confidently deliver messages
about their safety. Needed research includes rigorously conducted
randomised control trials, with follow-up past childbirth in order to
track pregnancy and infant outcomes. Care should also be taken to
ensure that practitioners routinely collect data on exposure to NRT,
e-cigarettes and smoking to enable accurate outcomes in studies
using routine data. The findings of this QES point to an apparent
gap in evidence, which should be addressed by more research
in low- and middle-income countries, as well as countries where
smoking prevalence in pregnancy is the highest, for example in
Ireland or Bulgaria (Lange 2018).
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Number of participants: 10
NRT/e-cig use: each participant had used NRT for 1-180 days (average 45)
Maternal status: all pregnant
Most (n = 8) used patches (7-15 mg), 2 used gum
Smoking status: no. of cigarettes smoked at the start of pregnancy: 5-20 (range), 5 smoked an average
of 20 cigarettes per day
Most (n = 8) participants commenced smoking before age 17
Age range: 25-39 years
Methods:
Study objectives: to raise professional awareness of women's concerns regarding smoking in pregnan-
cy and the use of NRT
Women were encouraged to offer their views on multiple aspects of NRT use in pregnancy
Study period: not provided
Theoretical perspective: phenomenological theoretical approach
Sampling: a purposive sample of a larger group of women who had previously accessed the local stop
smoking service
Data collection and analysis: semi-structured interviews, thematic analysis
Key themes relevant to the review:
1. Choice of product
2. Thoughts surrounding quit day with NRT
3. Length of time product used
4. Information
5. Anxieties regarding use of NRT
Sources of support
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Number of participants: 41
NRT/e-cig use: not reported
Maternal status: all pregnant, 10 interviewed again postpartum
Gestation: mean = 19 weeks
15% reported stopping smoking
All of area A (n = 20) and 20% area B were engaged with stop smoking services by the time of interview
5 participants from each area were interviewed again between 5-12 weeks postpartum but no relevant
data
Age at interview: mean 26 years
Methods:
Study objectives: to explore pregnant women's perspectives and experiences of the barriers to and fa-
cilitators of smoking cessation, and elicit their views on existing services and interventions to support
cessation
Women offered their views on NRT as part of the wider scope of the interviews.
Study period: November 2013 – December 2014
Theoretical perspective: social-ecological framework theoretical perspective
Sampling: women were recruited through maternity or stop smoking services. For the second inter-
view, purposive sampling was undertaken, taking into account maternal age, deprivation and smoking
status (continuing smokers or quitters).
Data collection and analysis: semi-structured interviews, thematic analysis
Key themes relevant to the review:
1. Nicotine replacement therapy (Chapter 6)
2. Electronic cigarettes (Chapter 11)
Sources of support
Employed by/associated with: University of Stirling; UK Centre for Tobacco and Alcohol Studies (UKC-
TAS); University of York; University of East Anglia; University of Cambridge; University of Glasgow
Funding: British Heart Foundation; Cancer Research UK; the Economic and Social Research Council;
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Study characteristics
Notes Context:




Number of participants: 29
NRT/e-cig use: not reported
Maternal status: 10 pregnant, 19 postpartum
Smoking status: current/former smokers or making a quit attempt
Age: range 15-49 years, mean 22.1 years
Education: 21 less than high school, 3 high school, 5 more than high school
Marital status: 18 had a partner, 11 were single
Ethnicity: 11 Aboriginal, 11 white, 4 Black, 1 West Indian, 1 Latin American, 1 not reported
Key informants - individuals with insight into the needs of pregnant or postpartum women who smoke
were also interviewed, but are not relevant to this review
Methods:
Study objectives: to examine cessation needs, barriers to the provision and uptake of cessation support
and directions for policy, practice, and programming
Study period: February 2011 – May 2011
Theoretical perspective: unclear
Sampling: participants were purposefully recruited, with promotion through the provincial cessation
helpline and gatekeepers working with the target population at local community agencies
Data collection and analysis: semi-structured interviews, thematic interpretive analysis
Key themes relevant to the review:
1. Inconsistent practice
2. Engagement and acceptability issues
Sources of support
Employed by/associated with: University of Toronto; Centre for Addiction and Mental Health, Canada
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Number of participants: 20
NRT/e-cig use: 8 had used or were using medication to help them quit (unclear as to whether this in-
cludes NRT)
Maternal status: 6 pregnant (1 in first trimester, 2 in second, 3 in the third), 14 recently given birth (2
gave birth 5-12 weeks ago; 7 gave birth 3 months to 1 year ago; 2 gave birth over a year ago; 3 = other)
Smoking status: 11 current smokers. Cigarettes per day: 8 smoked ≤ 10, 3 smoked 11-20
10 participants had made at least 1 quit attempt
Age: range = 17-38 years, mean 27 years
Ethnicity: 100% Aboriginal or Torres Strait Islander
Methods:
Study objectives: to privilege the voices of Aboriginal women, smokers and ex-smokers in the Hunter
New England area, collecting their experiences of smoking during pregnancy and of receiving smoking
cessation care
Study period: August 2015 – January 2016
Theoretical perspective: unclear
Sampling: some participants were recruited through Aboriginal health networks and a smoking cessa-
tion trial. The remainder were recruited through use of the researcher's familiarity with Aboriginal com-
munity networks, and a university project
Data collection and analysis: therapeutic yarning interviews, inductive thematic analysis
Key themes relevant to the review:
Attitudes towards NRT
Sources of support
Employed by/associated with: University of Newcastle, AU; James Cook University, AU; Clarence Spe-
cialist Clinic, AU
Funding:
RACGP Family Medical Care, Education and Research Grant
Australian Heart foundation Indigenous Scholarships
NHMRC
Cancer Institute NSW Early Career Research Fellowship
Sources of support
Employed by/associated with: University of Newcastle, Australia; James Cook University, Australia;
Clarence Specialist Clinic, Australia
Funding:
RACGP Family Medical Care, Education and Research Grant
Bovill 2018  (Continued)
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Number of participants: 14
NRT/e-cig use: 64% using NRT at time of interview. Forms of NRT used: 36% patches, 7% gum, 7% mi-
crotab, 43% inhalator, 7% patches, mouth spray and inhalator. E-cig use in pregnancy: 36% of partici-
pants
Maternal status: all pregnant
Gestation: mean 14 weeks
Number of cigarettes smoked before quit attempts: mean 14 per day
Smoking status: all participants smoked during their quit attempt; 72% were smoking at time of the in-
terview
Age: mean 28 years
Partner smoking status: 64% smoker, 27% non-smoker, 7% no partner
Ethnicity: 93% white, 7% mixed British and Caribbean
Methods:
Study objectives: to understand the experience of pregnant women using NRT who discontinue NRT
early or do not use the medication as it is recommended
Study period: May 2014 – December 2014
Theoretical perspective: unclear
Sampling: 2 stop smoking services were used as participant identification centres. Potentially eligible
women – those who had recently been prescribed NRT and used it during their quit attempt, but not as
recommended – were informed about the study
Data collection and analysis: semi-structured interviews, inductive thematic analysis
Key themes relevant to the review:
1. Expectations of NRT
2. Experience of using NRT (perceived effects of NRT use, concomitant smoking and side effects)
3. Safety concerns
4. Experience of e-cigarettes
Bowker 2016 
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Sources of support
Employed by/associated with: University of Nottingham; University of Cambridge










Number of participants: 30
NRT/e-cig use: 9 current e-cig users, 11 ex-users, 10 never users; 7 of the 9 current e-cig users were dual
users
Maternal status: 15 pregnant (t3 in 1st trimester, 7 in 2nd trimester, 5 in 3rd trimester), 15 postpartum (6
were 0-3 months postpartum, 9 were 4-6 months postpartum)
Smoking status: 16 current smokers, 14 ex-smokers
Age: range 21-38 years
Education: 70% did not continue education beyond 18
Employed: 83%
Living with partner: 70%
Ethnicity: 83% white British
Methods:
Study objectives: to explore pregnant and postpartum women's views and experiences of e-cigarettes
Study period: October 2015 – October 2016
Theoretical perspective: unclear
Sampling: participants were purposively sampled from the following groups: e-cig users, e-cig ex-users,
each trimester of pregnancy and for varying stages of the postpartum period (up to 6 months). Re-
cruitment adverts were placed on various websites and at stop smoking services, antenatal clinics and
health visitor clinics in locations across England and Scotland
Data collection and analysis: semi-structured interviews, thematic framework analysis
Key themes relevant to the review:
1. Motivations for use
2. Social stigma
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Sources of support
Employed by/associated with: University of Nottingham; University of Cambridge; University of Stirling;
St Georges University of London; UKCTAS










Number of participants: 19
NRT/e-cig use: not reported
Maternal status: 16 pregnant (5 in 1st trimester, 5 in 2nd trimester, 6 in 3rd trimester, mean gestation 21
weeks), 3 postpartum (had given birth in the past 10 months)
Smoking status: 74% current smokers (smoked between 1-30 cigarettes per day), 26% ex-smokers with
experience of 2 weeks – 5 months cessation. All had smoked for all or part of their pregnancy
11% had used a stop smoking service
Age: range 17-35 years, mean 25 years
Education: 21% no completed education, 32% completed compulsory education, 47% completed 1-5
years of higher education
Employment status: 58% unemployed/never worked, 21% carers, 16% employed, 5% not stated
Marital status: 53% parenting with partner, 47% parenting alone
Ethnicity: 95% white British, 5% non-white/Caribbean
Methods:
Study objectives: to report on the views held by past and current service users and non-users regarding
existing stop smoking services for pregnant women in Solihull, West Midlands.
Study period: January 2011 – May 2011 (recruitment of participants)
Theoretical perspective: unclear
Sampling: women within two postcode areas were targeted, based on regional statistics indicating
high rates of smoking in pregnancy. Participants were invited to participate at their initial contact with
smoking cessation services or from community midwife visiting lists
Data collection and analysis: focus groups, thematic analysis
Key themes relevant to the review:
1. Advantages of current services: non-judgmental support
2. Initiatives to encourage participation (offering suitable NRT subtheme)
Butterworth 2014 
Factors influencing the uptake and use of nicotine replacement therapy and e-cigarettes in pregnant women who smoke: a qualitative
evidence synthesis (Review)









Cochrane Database of Systematic Reviews
Sources of support
Employed by/associated with: Coventry University; Solihull NHS Care Trust
Funding: no funding received











Number of participants: 59
NRT/e-cig use: 28% of pregnant smokers and 19% of pregnant quitters used 'other tobacco products', a
category including e-cigs
Pregnant smokers (n = 32): Smoking status: 66% smoked every day, 28% used other tobacco products
(including e-cigs, snus, chewing tobacco)
Age: 41% 18-23 years, 44% 24-29 years, 13% 30-35 years, 3% 36-40 years
Education: 19% less than high school, 53% high school or equivalent, 28% some college
Ethnicity: 41% white, 19% African American, 13% Native American, 28% Hispanic
Pregnant quitters (n = 27): Smoking status: 19% used other tobacco products (including e-cigs, snus,
chewing tobacco)
Age: 7% 18-23, 22% 24-29, 33% 30-35, 37% 36-40
Education: 15% high school or equivalent, 59% some college, 22% college graduate
Ethnicity: 51% white, 29% African American, 3% Native American, 15% Latin American
The third group, smokers planning a pregnancy, are not relevant to this review
Methods:
Study objectives: to assess how women perceive emerging non-combusted tobacco products and NRT
use in general and during pregnancy, to assess how women perceive the health risks associated with
these
Study period: not provided
Theoretical perspective: unclear
Sampling: market research facilities recruited participants using their databases. Respondents were
then screened for eligibility by telephone
Data collection and analysis: focus groups, thematic analysis
England 2016 
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Key themes relevant to the review:
Prior experiences with tobacco and NRT (perceptions related to non-combustible tobacco and NRT,
general, subthemes = product familiarity, product appeal), specific and non-specific to pregnancy
Sources of support
Employed by/associated with: Centres for Disease Prevention and Control, USA; Centre for Tobacco
Products, US Food and Drug Administration, USA; RTI International, USA
Funding:











Number of participants: 19 (22 including 3 lifelong non-smokers)
NRT/e-cig use: not reported
Maternal status: participants ranged from 11 weeks gestation to postpartum (up to 6 weeks)
Smoking status: 86% current smokers, 14% lifelong non-smokers
Age: range 22-37 years, mean 28 years
Past pregnancies: range 1-15, mean 4, and mean of 2 living children, range 0-7 children
Ethnicity: 100% white
Methods:
Study objectives: to describe facilitators and barriers to engaging in tobacco treatment among preg-
nant, opioid-dependent women receiving medication-assisted treatment (MAT).
Study period: not provided
Theoretical perspective: unclear
Sampling: participants were recruited from group prenatal care sessions at a maternal fetal medicine
clinic
Data collection and analysis: focus groups, thematic analysis
Key themes relevant to the review:
Lack of success with NRT
Sources of support
Employed by/associated with: University of Kentucky, USA
Fallin 2016a 
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Funding: none reported










Number of participants: 12
NRT/e-cig use: not reported, but all participants smoked either cigarettes or e-cigs
Maternal status: 8 pregnant, 4 newly postpartum
Smoking status: all reported smoking (cigarettes or e-cigs) 3 months before pregnancy or during preg-
nancy
Marital status: 58.3% single
Ethnicity: 75% white
Methods:
Study objectives: to describe perceptions and beliefs about e-cigarette use during pregnancy among
pregnant and newly postpartum women in Kentucky
Study period: not provided
Theoretical perspective: unclear
Sampling: women who had taken part in the first phase of the study (a survey completed by a conve-
nience sample of pregnant women), and had consented to being contacted for additional studies, were
invited to attend a focus group, providing they met the eligibility criteria
Data collection and analysis: focus groups, content analysis
Key themes relevant to the review:
1. Attraction to e-cig as a harm reduction strategy
2. Uncertainty regarding the health effects of e-cigs
3. Ambivalence regarding novel product characteristics
4. Behaviours reflected dual use and often complete relapse to traditional cigarettes
5. Lack of success with NRT
Sources of support
Employed by/associated with: University of Kentucky, USA
Funding: NIH; American Cancer Society Institutional Research Grant; Centres for Medicare and Medic-
aid Services; Centres for Medicare and Medicaid Innovation
Fallin 2016b 
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Number of participants: 6
NRT/e-cig use: not reported
Maternal status: all pregnant
Gestation: range 20-35 weeks, mean 27 weeks
Smoking status at recruitment: all daily smokers, with experience of at least one health worker deliv-
ered intervention for smoking cessation during their pregnancy
Smoking status at interview: 4 smoking, 1 had quit in the last 4 weeks, 1 quit without support
Age: range 18-38 years, mean 24.33 years
Previous pregnancies: 4 having 1st baby, 1 having 3rd, 1 having 4th
All were socioeconomically disadvantaged - all held a government health card (indicator of low in-
come). All participants lived in public housing
Marital status: all women had partners, 3 cohabiting, 3 living with parents
Methods:
Study objectives: to explore and describe women's experiences of smoking cessation intervention(s),
perceptions of smoking cessation intervention efficacy, and views for improving smoking cessation in-
terventions in pregnancy
Study period: not provided
Theoretical perspective: feminist
Sampling: purposive sample – 5 women were identified and recruited from a smoking cessation service
database. One other was recruited opportunistically via snowball sampling
Data collection and analysis: semi-structured interviews, inductive thematic analysis
Key themes relevant to the review:
What NRT women want
Sources of support
Employed by/associated with: Flinders University, Australia
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Study characteristics
Notes Geographical context:




Number of participants: 60
NRT/e-cig use: not reported
Maternal status: all pregnant (43% 2nd trimester, 40% 3rd)
Smoking status: mostly current smokers (one recently stopped smoking on becoming pregnant)
Cigarettes per day: range 1-28, mean 9, 32% smoked 1st cigarette within 5 minutes of waking
Age range: 17-43 years
Previous pregnancies: 38% having 1st baby
68% lived in urban centres
Education: 23% no formal qualifications
Employment status: 38% had some employment, 80% eligible for community services card - an indica-
tor of low income
Marital status: 88% with a partner
Ethnicity: 100% Maori
Methods:
Study objectives: to investigate pregnant Maori smokers' perception of cessation services and products
and identify how they may be improved
Study period: October 2002 – November 2003
Theoretical perspective: unclear
Sampling: participants were recruited through Maori health services, the researcher's networks and
newspaper advertisements from various urban and rural areas of New Zealand's North Island
Data collection and analysis: semi-structured interviews, inductive thematic analysis
Key themes relevant to the review:
1. Health education resources
2. Nicotine replacement therapy
Sources of support
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Study characteristics
Notes Geographical context:




Number of participants: 10 (9 completed both interview phases). This number of participants was
deemed appropriate by the authors due to the highly in-depth nature of the study
NRT/e-cig use: 1 participant used an e-cig.
Maternal status: all pregnant
Gestation: mean gestation 12.9 weeks (range 6-29 weeks)
Smoking status: 2 smoked at time of interview, 1 was using an e-cig, 5 abstinent, 1 did not mention
smoking
Age: range 24-34 years, mean 28.8 years
Previous pregnancies: 9 already had children, one participant gave birth as a teenager, another in 30s,
rest occurred in 20s
Socioeconomic status: all living in areas of the highest quintile of deprivation and claiming means test-
ed benefits (welfare)
Methods:
Study objectives: to gain an in-depth understanding of the health issues affecting 10 low-income preg-
nant women from deprived areas of south Wales, UK
Study period: March 2016 – August 2016
Theoretical perspective: an interpretivist paradigm guided by feminist principles
Sampling: recruitment of participants was achieved through a variety of avenues external to health ser-
vices, including community settings, online advertising and flyers in deprived areas
Data collection and analysis: 3 creative tasks based on visual methods, and elicitation interviews, the-
matic analysis.
Key themes relevant to the review:
1. Demographics and (self-reported) smoking status
2. Social networks, hidden smoking during pregnancy and morality
3. Interaction with maternity healthcare services
Sources of support
Employed by/associated with: CardiG University; Queen's University Belfast; UK
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Number of participants: 36
NRT/e-cig use: not reported
Maternal status: all pregnant
Smoking status: all smokers
Age: range 16-24 years (50% 16-17 years)
Parity: 78% in first pregnancy
Ethnicity: 14% Aboriginal, all English-speaking
Methods:
Study objectives: to gain insight into the perceived challenges and enablers young pregnant women
encounter when attempting to modify their smoking
Study period: July 2011 – June 2012
Theoretical perspective: unclear
Sampling: participants were recruited by a research assistant whilst attending an antenatal clinic ap-
pointment
Data collection and analysis: interviews, thematic analysis
Key themes relevant to the review:
Something you could take
Sources of support
Employed by/associated with: Curtin University and King Edward Memorial Hospital, Australia
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Number of participants: 13. Data saturation appeared to be reached, and no new themes emerged in
the final 3 interviews
NRT/e-cig use: not reported
Maternal status: all pregnant
Smoking status: 54% reported they had quit at time of interview, 69% had previously made a quit at-
tempt
Age: range 20-41 years, mean 31 years
Marital status: 92% married
Previous pregnancies: 38% 1st pregnancy, 62% multigravida
Ethnicity: 92% white British
Methods:
Study objectives: to explore the needs and preferences of pregnant women seeking online stop smok-
ing support (with an aim to identify features and components of Internet-based smoking cessation in-
terventions that might be most attractive to this population)
Study period: not provided
Theoretical perspective: unclear
Sampling: participants were women randomised to the intervention arm of a smoking cessation trial
(MumsQuit)
Data collection and analysis: semi-structured interviews, framework analysis variant
Key themes relevant to the review:
Smoking cessation medication
Sources of support
Employed by/associated with: University College London; National Centre for Smoking Cessation and
Training, London, UK
UCL Tobacco and Alcohol Research Group
Funding: National Prevention Research Initiative
The Funding Partners relevant to this award are (in alphabetical order): Alzheimer's Research Trust;
Alzheimer's Society; Biotechnology and Biological Sciences Research Council; British Heart Founda-
tion; Cancer Research UK; Chief Scientist Office, Scottish Government Health Directorate; Department
of Health; Diabetes UK; Economic and Social Research Council; Engineering and Physical Sciences Re-
search Council; Health & Social Care Research & Development Office for Northern Ireland; Medical Re-
search Council; the Stroke Association; Welsh Assembly Government. British Heart Foundation PhD
Studentship; Society for the Study of Addiction; Cancer Research UK
Conflict of interests: Pfizer. RW undertakes consultancy and research for and receives travel funds and
hospitality from manufacturers of medications for smoking cessation. He also undertakes training for
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Number of participants: 19
NRT/e-cig use: not reported (NRT was not approved for use in pregnancy in Australia at the time the
study was conducted)
Maternal status: all pregnant
Smoking status: women who smoked (n = 9) or who had quit before or early in pregnancy (n = 10)
Methods:
Study objectives: to explore barriers to quitting smoking for pregnant women, their attitudes to use of
patches and their perceptions of care provider counselling
Study period: not provided
Theoretical perspective: unclear
Sampling: convenience sample: a researcher approached women at 5 successive antenatal clinics at a
large obstetrics hospital in South Australia. Over 250 women were approached to take part
Data collection and analysis: focus groups, thematic analysis
Key themes relevant to the review:
Attitudes of women towards the use of nicotine patches
Sources of support
Employed by/associated with: Women's and Children's Hospital Australia; Flinders University, Aus-
tralia; University of South Australia










Number of participants: 36 (20 incentives arm, 16 control arm)
NRT/e-cig use: not reported
Maternal status at interview: 24 pregnant, 11 postpartum (6 in incentive group and 5 in control group);
1 participant miscarried
Mantzari 2012 
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Smoking status: at interview: 12 (33%) women smoke-free (8 in intervention group, 4 in control group),
24 (66%) smoking
Age: range 17-43 years, mean 28 years
Employment status: mostly unemployed
Ethnicity: 94% white
Methods:
Study objectives: to examine and compare the stop-smoking experiences of pregnant women who
were versus were not incentivised for smoking cessation
Study period: September 2009 – May 2010 (recruitment of participants)
Theoretical perspective: unclear
Sampling: participants were recruited through an opportunistic sampling framework from a popula-
tion of 115 women living in the greater Birmingham area who had been referred to the NHS Stop Smok-
ing Services by their midwives and were either enrolled in a pilot scheme of incentivising smoking ces-
sation or lived in a comparison area, and were therefore eligible to be part of a comparison cohort
Data collection and analysis: semi-structured interviews, framework analysis
Key themes relevant to the review:
Perceived inhibitors
Sources of support











Number of participants: 20
NRT/e-cig use: not reported
Maternal status: 15 pregnant (75%), 5 postpartum (25%)
Age range: 16-40 years
Gestation: 5% 1-12 weeks, 30% 13-28 weeks, 40% 29-40 weeks
Smoking status: 13 (65%) current smokers
Cigarettes per day in pregnancy: 35% 0, 20% 1-4, 30% 5-9, 5% 15-19, 10% 20+
Naughton 2013 
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Quit attempts: 1 participant quit during most recent pregnancy (but smoked for first 4); 6 quit when
finding out they were pregnant; the remaining 13 smoked but had made numerous quit attempts
Previous births: 65% had no previous births
National Statistics socioeconomic classification (1-5): 45% 1, 5% 2, 5% 3, 5% 4, 40% 5
Relationship status: 90% had a partner
Partner smoking status: 77.8% smoked
Methods:
Study objectives: to explore the accounts of pregnant smokers and quitters, to investigate the role of
their smoking beliefs in influencing their smoking behaviour and the relationships of these with psy-
chosocial factors related to pregnancy and antenatal care
Study period: March 2007 – July 2007
Theoretical perspective: grounded theory and constant comparative approach
Sampling: purposive sampling. Participants were recruited by community midwives from two GP prac-
tices in Cambridgeshire and Suffolk, UK. Midwife clinics and a 'SureStart' programme were attended by
one of the authors towards the end of recruitment to identify further participants and ensure sample
variation
Data collection and analysis: semi-structured interviews, framework analysis
Key themes relevant to the review:
Uncertainty about the mechanism of harm
Sources of support
Employed by/associated with: University of Cambridge; University of Leicester










Number of participants: 6. Data saturation was achieved so no more interviews were carried out.
NRT/e-cig use: not reported
Maternal status: had been pregnant at time of contact with stop smoking service (between July 2012
and July 2013)
Smoking status: smoked at time of referral to stop smoking service
Age: range 18-35 years
Pledger 2015 
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Methods:
Study objectives: to retrospectively examine the needs, motivations and experiences of pregnant
women using an NHS stop smoking service. Identify enablers and barriers to stop smoking in expectant
mothers
Study period: August 2013 – September 2013
Theoretical perspective: unclear
Sampling: purposive sample. The researcher contacted all eligible participants who had contacted an
NHS stop smoking service in the preceding 12 months, identifying 82 potential participants
Data collection and analysis: semi-structured interviews, comparative analysis.
Key themes relevant to the review:
Experiences of using NHS stop smoking support
Sources of support











Number of participants: 20
NRT/e-cig use: not reported. As part of the financial incentives scheme this study is part of, NRT was
provided by pharmacist at an initial meeting.
Maternal status: all pregnant
Age: mean 25.7 years
Socioeconomic status: majority living in most deprived quintile
Previous pregnancies: over half (n = 12) of participants were having their 1st child
Methods:
Study objectives: to seek the views and experiences of 2 participant groups with divergent levels of en-
gagement to a pilot smoking cessation incentive scheme
Study period: early 2009
Theoretical perspective: unclear
Radley 2013 
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Sampling: a cross-sectional sample of participants in the 'Give It Up For Baby' incentives scheme was
identified using client databases to represent the 2 groups of interest: those that engaged regularly
with the scheme, and those that registered but did not
Data collection and analysis: interviews, thematic analysis
Key themes relevant to the review:
Client typology
Sources of support
Employed by/associated with: NHS Tayside; University of Stirling; University of Dundee; University of
Glasgow










Number of participants: 18
NRT/e-cig use: 7 of the pregnant sample and 2 of the postpartum sample reported past NRT use
Pregnant sample (n = 14)
Gestation: range = 9-28 weeks
Smoking status: 10 smokers, 4 recently quit. Cigarettes per day: average = 8.3 had used a stop smoking
service previously
Age: range 17-36 years
Marital status: 8 cohabiting with partner, 1 married, 5 single
Employment status: 5 employed
Education: 7 National Vocational Qualifications/General Certificate of Secondary Education level, 1
Diploma/Higher National Diploma level, 1 degree level
Ethnicity: 100% white British
Postpartum sample (n = 4)
6-20 months postpartum
Smoking status: 3 smoked throughout pregnancy, 1 quit during pregnancy. Mean cigarettes per day
whilst pregnant = 9
Age: range 21-32 years
Marital status: 3 cohabiting with partner, 1 married
Taylor 2010 
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Employment status: 2 employed
Education: 2 National Vocational Qualifications/General Certificate of Secondary Education, 1 Business
and Technology Education Council/A Level, 1 degree level
Ethnicity: 100% white British
The third sample, NHS health professionals, is not relevant to this review
Methods:
Study objectives: to elicit salient beliefs women have about NRT
Study period: August 2006 – February 2007
Theoretical perspective: theory of planned behaviour framework
Sampling: purposive sampling (maximum variation sampling strategy) in order to recruit participants
from across the social spectrum, recruited from antenatal clinics and SureStart centres
Data collection and analysis: semi-structured interviews, thematic analysis
Key themes relevant to the review:
1. Effective for quitting - beliefs about whether or not NRT would be effective in helping with smoking
cessation
2. Side effects - beliefs about unwanted side effects accompanying NRT use
3. Improved health - beliefs that using NRT in pregnancy would improve the health of mother and baby
4. Not the same as quitting - beliefs that using NRT would not represent properly quitting smoking
5. Safety - beliefs that NRT might not be safe to use in pregnancy,
6. Unsure if allowed - beliefs that NRT might not be allowed in pregnancy
7. Knowledge about products - the amount of knowledge a pregnant woman has about NRT
Sources of support
Employed by/associated with: University of Nottingham, UK
Funding: MRC (PhD thesis)
Taylor 2010  (Continued)
NIH: National Institutes of Health; NHMRC: National Health and Medical Research Council (Australia); MAT: medication-assisted treatment;
NRT: nicotine replacement therapy; RACGP: Royal Australian College of General Practitioners; UKCTAS: UK Centre for Tobacco and Alcohol
Studies
 
Characteristics of excluded studies [ordered by study ID]
 
Study Reason for exclusion
Anderson 2002 Not about NRT or e-cigarettes
Ashford 2008 No full text available
Ashford 2011 Not about NRT or e-cigarettes
Askew 2019 Not about NRT or e-cigarettes
Balwicki 2017 Not a qualitative study
Bottorff 2006 Not about NRT or e-cigarettes
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Study Reason for exclusion
Britton 2017 Not about NRT or e-cigarettes
Bryce 2009 Not about NRT or e-cigarettes
Bull 2007 Not about NRT or e-cigarettes
Bull 2008 Ineligible patient population
Colomar 2015 Not about NRT or e-cigarettes
Constantine 2014 Not about NRT or e-cigarettes
Cottrell 2007 Not about NRT or e-cigarettes
Davidson-Harden 2009 Not a qualitative study
Edwards 1998 Not about NRT or e-cigarettes
Gillam 2009 Not about NRT or e-cigarettes
Glover 2014 Ineligible patient population
Goszczynska 2016 Not about NRT or e-cigarettes
Gould 2013 Not about NRT or e-cigarettes in pregnancy
Gould 2017a Not a qualitative study
Gould 2017b Not about NRT or e-cigarettes
Griffis 2016 Not about NRT or e-cigarettes
Haslam 2001 Not about NRT or e-cigarettes
Herberts 2012 Not about NRT or e-cigarettes
Hoek 2014 Not about NRT or e-cigarettes
Homish 2012 Not a qualitative study
Hotham 2005 Inegible study design
Howard 2013 Not about NRT or e-cigarettes
Kahr 2015 Ineligible patient population
Kennison 2003 Not about NRT or e-cigarettes
Koshy 2010 Not about NRT or e-cigarettes
Lawson 1991 No full text available
Lowry 2004 Not about NRT or e-cigarettes
Mann 2018 Not a qualitative study
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Study Reason for exclusion
Maubach 2013 Not about NRT or e-cigarettes
McCurry 2002 Not about NRT or e-cigarettes
McLeod 2003 Not about NRT or e-cigarettes
Modeste 2004 Ineligible study design
Naughton 2013a Not about NRT or e-cigarettes
Nguyen 2012 Not about NRT or e-cigarettes
Park 2009 Not about NRT or e-cigarettes
Passey 2018 Not about NRT or e-cigarettes
Petersen 2010 Not about NRT or e-cigarettes
Pletsch 1996 Not about NRT or e-cigarettes
Pletsch 2003 Not about NRT or e-cigarettes
Pletsch 2004 Not about NRT or e-cigarettes
Quinn 2006 Not about NRT or e-cigarettes
Ronchi 2018 Not about NRT or e-cigarettes
Tod 2003 Not about NRT or e-cigarettes
Wigginton 2017 Ineligible patient population
Wood 2008 Not about NRT or e-cigarettes
Wu 2017 Not about NRT or e-cigarettes
NRT: nicotine replacement therapy.
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FACTORS INFLUENCING USE OF NRT IN PREGNANCY FACTORS INFLUENCING E-CIGARETTE USE IN
PREGNANCY
Theme 1: safety concerns about nicotine – women's beliefs about safety of nicotine-containing products influence their use in
pregnancy
Finding 1 : women believe that NRT is safer than smoking in general.
Finding 2 : women are concerned that NRT can deliver an unsafe amount of
nicotine.
Finding 3 : women are concerned that using NRT during pregnancy can harm
their baby.
Finding 4 : women believe that e-cigarettes are
safer than smoking in general.
Finding 5 : women are concerned that e-ciga-
rettes can deliver an unsafe amount of nicotine.
Finding 6 : women are concerned that using e-cig-
arettes during pregnancy can harm their baby.
Theme 2: concerns about addictiveness of nicotine – women's beliefs about addictiveness of nicotine influence their use of
NRT in pregnancy
Finding 7 : women report concerns that NRT is as addictive as smoking.  
Theme 3: effectiveness of nicotine-containing products – women's beliefs about the effectiveness of nicotine-containing prod-
ucts influence their use in pregnancy
Finding 8 : past positive experiences of NRT can facilitate NRT use in pregnancy.
Finding 9 : past negative experiences with NRT can be a barrier to NRT use in
pregnancy.
Finding 10 : women present mixed views on effec-
tiveness of e-cigarettes.
Theme 4: side effects – women's beliefs about and experiences with side effects of NRT influence their use in pregnancy
Finding 11 : women who report experiencing and feeling unable to deal with
side effects of NRT, perceive these as a barrier to NRT use in pregnancy.
 
Theme 5: influence of others – women's readiness to use nicotine-containing products in pregnancy is influenced by the per-
ceived views of and support from other people
Finding 12 : women who report receiving clear and consistent reassurance from
health professionals about NRT safety in pregnancy feel this can facilitate NRT
use.
Finding 13 : women who report experiencing lack of support towards NRT use
from health professionals are reluctant to use NRT in pregnancy.
Finding 14 : women feel discouraged from using NRT in pregnancy by the per-
ceived views and experiences of other people (non-health-professionals).
Finding 15 : women's readiness to use e-ciga-
rettes in pregnancy is influenced by the advice
they report receiving from their health profession-
als.
Finding 16 : women's readiness to use e-ciga-
rettes in pregnancy is influenced by other people
(non-professionals).
Theme 6: characteristics of nicotine-containing products can influence women's readiness to use them in pregnancy
Finding 17 : perceived characteristics of the NRT product, such as cost, conve-
nience and ability to mimic a cigarette, can influence uptake and continuous
use of NRT in pregnancy.
Finding 18 : perceived characteristics of e-ciga-
rettes, such as cost, convenience and ability to
mimic a cigarette, can influence uptake and con-
tinuous use of e-cigarettes in pregnancy.
Table 2.   Short overview of themes and findings 
NRT: nicotine replacement therapy.
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Finding Overall CERQual assessment Explanation for assessment Contributing studies
Theme 1: safety concerns about nicotine – women's beliefs about safety of nicotine-containing products influence their readi-
ness to use it in pregnancy













Moderate confidence Moderate concerns regard-
ing relevance and minor con-
cerns about methodological
issues, coherence, and ade-
quacy
Ashwin 2010; Bauld 2017;
Bowker 2016; Hotham 2002;
Naughton 2013; Taylor 2010















Moderate confidence Moderate concerns about ad-
equacy and minor concerns
about methodical issues
Borland 2013; Bowker 2016;
Butterworth 2014; England
2016; Hotham 2002; Naughton
2013; Taylor 2010












High confidence — Ashwin 2010; Bauld 2017; Bor-
land 2013; Bovill 2018; Bowk-
er 2016; Butterworth 2014; Eng-
land 2016; Glover 2012; Hotham
2002; Naughton 2013; Radley
2013; Taylor 2010











Moderate confidence Moderate concerns about co-
herence and minor concerns
about methodological issues
and adequacy
Bauld 2017; Bowker 2018; Eng-
land 2016; Fallin 2016b; Grant
2020
Table 3.   Summary of findings 
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Low confidence Moderate concerns about rel-
evance and adequacy, and
minor concerns about coher-
ence and methodological is-
sues
Bowker 2018; England 2016;
Fallin 2016b














Moderate confidence Moderate concerns about rel-
evance and minor concerns
about adequacy
Bauld 2017; Bowker 2016;
Bowker 2018; Fallin 2016b
Theme 2: concerns about addictiveness of nicotine – women's beliefs about addictiveness of nicotine influence their readiness
to use NRT in pregnancy
7 Finding 4 , NRT: women report con-





Moderate concerns about rel-
evance and adequacy, minor
concerns about methodolog-
ical issue
Ashwin 2010; Bowker 2016; Eng-
land 2016; Taylor 2010
Theme 3: beliefs about effectiveness of nicotine-containing products – women's beliefs about the effectiveness of nico-
tine-containing products influence their use in pregnancy
8 Finding 8, NRT : women who had
positive experience with NRT or
who knew someone that had report
greater readiness to use it in pregnan-
cy.







Bauld 2017; Bowker 2016; But-
terworth 2014; Pledger 2015;
Taylor 2010
9 Finding 9, NRT : women who had
past negative experiences with NRT,
or heard from others who had nega-
Moderate confidence Moderate con-
cerns about
methodologi-
Ashwin 2010; Bauld 2017; Bowk-
er 2016; England 2016; Fallin
Table 3.   Summary of findings  (Continued)
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tive experiences with NRT being inef-






2016a; Hotham 2002; Mantzari
2012; Pledger 2015; Taylor 2010
10 Finding 10, e-cigarettes : women
present mixed views on effectiveness
of e-cigarettes.






Bauld 2017; Bowker 2016;
Bowker 2018; Grant 2020
Theme 4: side effects associated with NRT – women's beliefs about and experiences with side effects of NRT influence their
readiness to use NRT in pregnancy
11 Finding 11, NRT : women report that
experiencing and feeling unable to
deal with side effects of NRT is a bar-
rier to using it in pregnancy.
High confidence — Ashwin 2010; Bauld 2017; Bovill
2018; Bowker 2016; Butterworth
2014; England 2016; Mantzari
2012; Pledger 2015; Taylor 2010
Theme 5: influence of others – women's readiness to use nicotine-containing products in pregnancy is influenced by the per-
ceived views of and support from other people
12 Finding 12, NRT : women report that
receiving clear and consistent reas-
surance from health professionals
about NRT safety in pregnancy can
facilitate NRT use.





Ashwin 2010; Bauld 2017; Bowk-
er 2016; Gamble 2015; Hotham
2002; Taylor 2010
13 Finding 13, NRT : women report that
experiencing lack of support towards
NRT use in pregnancy from health
professionals is a barrier to NRT use.
High confidence — Borland 2013; Bovill 2018;
Bowker 2016; Gamble 2015;
Glover 2012; Hauck 2013;
Herbec 2014; Hotham 2002;
Mantzari 2012; Pledger 2015;
Taylor 2010
14 Finding 14, NRT : women feel dis-
couraged from NRT use in pregnan-
cy by the perceived views and expe-
riences of other people (non-health-
professionals).







Bovill 2018; England 2016;
Hotham 2002; Taylor 2010
15 Finding 15, e-cigarettes : women's
readiness to use e-cigarettes in preg-
nancy is influenced by the advice
they report receiving from health pro-
fessionals.
High confidence — Bauld 2017; Bowker 2016;
Bowker 2018; Fallin 2016b;
Grant 2020
16 Finding 16, e-cigarettes : women's
readiness to use e-cigarettes in preg-
nancy is influenced by other people
(non-health professionals).




Bauld 2017; Bowker 2018; Grant
2020
Theme 6: characteristics of nicotine-containing products – women's views on characteristics of the nicotine-containing prod-
ucts can influence their readiness to use these in pregnancy
Table 3.   Summary of findings  (Continued)
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17 Finding 17, NRT : perceived charac-
teristics of the NRT product, such as
cost, convenience and ability to mim-
ic a cigarette, can influence uptake
and continuous use of NRT in preg-
nancy.
High confidence — Ashwin 2010; Bauld 2017; Bowk-
er 2016; Bowker 2018; Butter-
worth 2014; England 2016; Fallin
2016a; Fallin 2016b; Hotham
2002; Pledger 2015; Radley
2013; Taylor 2010
18 Finding 18, e-cigarette : perceived
characteristics of e-cigarettes, such
as cost, convenience and ability to
mimic a cigarette, can influence up-
take and continuous use of e-ciga-
rettes in pregnancy.





Bauld 2017; Bowker 2018; Eng-
land 2016; Fallin 2016b
Table 3.   Summary of findings  (Continued)
NRT: nicotine replacement therapy.
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Ashwin 2010 NRT x   x       x   x   x x         x  
Bauld 2017 NRT x   x x   x   x x x x x     x x x x
Borland 2013 NRT   x x                   x          
Bovill 2018 NRT     x               x   x x        
Bowker 2016 NRT x x x     x x x x x x x x   x   x  
Bowker 2018 e-cig       x x x       x         x x x x
Butterworth 2014 NRT   x x         x     x           x  
England 2016 Both x x x x x   x   x   x     x     x x
Fallin 2016a NRT                 x               x  
Fallin 2016b e-cig       x x x                 x   x x
Gamble 2015 NRT                       x x          
Glover 2012 NRT     x                   x          
Grant 2020 e-cig       x           x         x x    
Hauck 2013 NRT                         x          
Herbec 2014 NRT                         x          
Hotham 2002 NRT x x x           x     x x x     x  
Mantzari 2012 NRT                 x   x   x          
Naughton 2013 NRT x x x                              



























































































































































































Pledger 2015 NRT               x x   x   x       x  
Radley 2013 NRT     x                           x  
Taylor 2010 NRT x x x       x x x   x x x x     x  
Table 4.   Qualitative findings matrix  (Continued)
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A P P E N D I C E S
Appendix 1. Search strategies
MEDLINE Ovid (1946 to 1 February 2019)
1. Pregnancy/






8. (ante*natal or antenatal).tw,kf.
9. (pre*natal or prenatal).tw,kf.
10. (postpartum or post*partum).tw,kf
11. (postnatal or post*natal).tw,kf.
12. “Tobacco Use Cessation”/
13. “Tobacco Use Cessation Products”/
14. Nicotinic Agonists/
15. Smoking Cessation Agents/
16. Nicotine Chewing Gum/
17. NRT.ti,ab.
18. nicotine replacement.tw,kf.
19. ((nicotine or tobacco) adj2 (gum* or lozenge* or patch* or spray*)).tw,kf.
20. (pharmaco* adj2 (nicotine or tobacco or smoking)).tw,kf.
21. smoking cessation.tw,kf.






28. (nicotine and vap*).tw,kf.
29. exp ANIMALS/ not HUMANS
30. 1 or 2 or 3 or 4 or 5 or 6 or 7 or 8 or 9 or 10 or 11
31. 12 or 13 or 14 or 15 or 16 or 17 or 18 or 19 or 20 or 21 or 22 or 23 or 24 or 25 or 26 or 27 or 28
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32. 30 and 31
33. 32 not 29
NB: No filters for qualitative terms will be used, as these are not consistently eGective across databases.
CINAHL EBSCO (Cumulative Index to Nursing and Allied Health Literature; 1937 to 1 February 2019)
S29 S26 AND S27 (Limiters: Medline and animal studies excluded)
S28 S26 AND S27
S27 (S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25)
S26 (S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10)
S25 TI (“nicotine” and “vap*”) OR AB (“nicotine” and “vap*”) OR (“nicotine” and “vap*”)
S24 TI electronic nicotine OR AB electronic nicotine OR electronic nicotine
S23 TI electronic cigarette OR AB electronic cigarette OR electronic cigarette
S22 TI ecig* OR AB ecig*
S21 TI e-cig* OR AB e-cig*
S20 TI e-cigarette* OR AB e-cigarette*
S19 TI vap* OR AB vap*
S18 (MH “Electronic Cigarettes”)
S17 “smoking cessation”
S16 TI (nicotine and (gum* or lozenge* or spray* or patch*)) OR AB (nicotine and (gum* or lozenge* or spray* or patch*))
S15 TI nicotine replacement OR AB nicotine replacement
S14 TI NRT OR AB NRT
S13 (MH “Smoking Cessation”)
S12 (MH “Nicotine Chewing Gum” OR (MH “Nicotine Patch”)
S11 (MH (“Nicotine Replacement Therapy”) OR (MH “Tobacco Use Cessation Products+”) OR (MH “Nicotinic Agonists+”)
S10 TI postpartum OR AB postpartum
S9 TI postnatal OR AB postnatal
S8 TI prenatal OR AB prenatal
S7 TI ante*natal OR AB ante*natal
S6 TI antenatal OR AB antenatal
S5 TI pregnan* OR AB pregnan*
S4 (MH “Postnatal Period+”)
S3 (MH “Expectant Mothers”)
S2 (MH “Prenatal Care”)
S1 (MH “Pregnancy+”) OR (MH “Pregnancy in Adolescence+”) OR (MH “Pregnancy Trimesters+”) OR (MH “Pregnancy Outcomes”)
PsycINFO Ovid (1967 to 1 February 2019)
1. exp PREGNANCY/ or exp ADOLESCENT PREGNANCY/ or exp PREGNANCY OUTCOMES/
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9. exp Postnatal Period/ or exp Perinatal Period/
10. 1 or 2 or 3 or 4 or 5 or 6 or 7 or 8 or 9







18. (pharmaco* and (nicotine or tobacco or smoking)).ti,ab.
19. Smoking cessation.ti,ab.





25. (nicotine and (vaporizer* or vapourizer* or vaporiser* or vapouriser* or vape* or vaping)).ti,ab.
27. exp ANIMALS/ not HUMANS/
28. 10 and 26
29. 28 not 27
Appendix 2. Inclusion and exclusion criteria
 
Inclusion criteria Exclusion criteria
Study type
• Primary qualitative study
• Uses qualitative data collection methods (such as focus groups, interviews, open-ended ques-
tionnaires, diaries and other appropriate narrative method
• Uses qualitative data analysis methods (such as interpretative phenomenological analysis, the-
matic, narrative, framework or similar analysis)
• Quantitative study
• Mixed methods study with-
out a distinct qualitative
component
• Study where only descrip-
tive statistics (non-qualita-
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• Mixed-methods studies that include a distinct qualitative component, as described above tive methods) were used to
analysed qualitative data
Phenomenon of interest
• Studies that explore experiences, views or opinions on NRT or e-cigarettes, of women who either




• Pregnant women who smoke or smoked at any point of their pregnancy or
• Women in the postpartum period, who smoked at any point during their pregnancy
• Study participants would not need to have experience of using NRT or e-cigarettes, as we are
broadly interested in determinants of use/not use rather than just women's views formed after
using NRT or e-cigarettes (but if they don't have experience of using NRT or e-cigs in pregnancy,
they must have experience of smoking in pregnancy).
• Health professionals







Appendix 3. Wallace criteria for appraising qualitative evidence
 
Question Essential or desir-
able?
1 Is the research question clear? Essential
2 Is the theoretical or ideological perspective of the author (or funder) explicit Desirable
3 Is study design appropriate to answer the question? Essential
4 Is the context or setting adequately described? Desirable
5 Sample adequate to explore range of subjects or settings? Essential
6 Sample drawn from appropriate population? Essential
7 Data collection adequately described? Essential
8 Data collection rigorously conducted? Essential
9 Data analysis rigorously conducted? Essential
10 Is there evidence of reflexivity? Desirable
11 Are findings substantiated by the data and limitations considered Essential
12 Claims to generalisability follow from the data? Desirable
13 Have ethical issues been addressed? Desirable
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Appendix 4. Ames et al data richness scale
 
Score Measure Example
1 Very few qualitative data present-
ed. Findings that are presented
are fairly descriptive
For example, a mixed-methods study using open-ended survey questions
or a more detailed qualitative study where only part of the data relates to
the synthesis objective
2 Some qualitative data presented For example, a limited number of qualitative findings from a mixed-meth-
ods or qualitative study
3 A reasonable amount of qualita-
tive data
For example, a typical qualitative research article in a journal with a small-
er word limit and often using simple thematic analysis
4 A good amount and depth of
qualitative data
For example, a qualitative research article in a journal with a larger word
count that includes more content and setting descriptors and a more in-
depth presentation of the findings
5 A large amount and depth of
qualitative data




Appendix 5. GRADE QERQual evidence profiles of qualitative findings
GRADE CERQual evidence profile: finding 1
 
Finding 1 , NRT: women believe that NRT is safer than smoking in general population; they believe NRT contains fewer harmful chem-
icals than traditional cigarettes.
Assessment for each CERQual component
Methodological limitations Minor concerns: 2 studies moderate (unclear sampling adequacy, insufficiently described data col-
lection or insufficiently rigorous data analysis) and all 6 studies had some minor issues
Coherence Minor concerns: some opposing cases in 2 studies.
Relevance Minor concerns: most studies from the UK, but from diverse settings, 1 study from Australia.
Adequacy Moderate concerns: 6 studies contributed relatively thin data.
Overall CERQual assessment




Ashwin 2010 England, UK; urban and rural; pregnant women; views on using NRT in pregnancy
Bauld 2017 England and Scotland, UK; urban and rural; pregnant and postpartum women; perspectives and
experiences of barriers to and facilitators of smoking cessation
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Bowker 2016 England, UK; pregnant women; understanding pregnant smokers' adherence to NRT
Hotham 2002 Australia; urban; pregnant women; pregnant smokers' barriers to cessation, attitudes to NRT and
perceptions of cessation counselling
Naughton 2013 Cambridgeshire and Suffolk, England, UK; urban and rural; pregnant and postpartum women; dis-
sonance and disengagement in pregnant smokers
Taylor 2010 UK; pregnant and postpartum women; beliefs about stop smoking services and NRT in pregnancy
  (Continued)
 
CERQual evidence profile: finding 2
 
Finding 2 , NRT: women are concerned that NRT can deliver an unsafe amount of nicotine, higher than a traditional cigarette, for ex-
ample because of constant delivery from a patch or from higher dose patches.
Assessment for each CERQual component
Methodological limitations Minor concerns: 2 studies with moderate issues relating to data collection and or/analysis and all 7
with minor methodological issues
Coherence No or very minor concerns
Relevance No or very minor concerns
Adequacy Moderate concerns: 6 studies contributed, but 3 reporting very thin data
Overall CERQual assessment
Moderate confidence Moderate concerns about adequacy and minor concerns about methodical issues
Contributing studies
Study Context
Borland 2013 Ontario, Canada; urban and rural; pregnant and postpartum women; exploring adequacy of stop
smoking support for pregnant and postpartum women
Bowker 2016 England, UK; pregnant women; understanding pregnant smokers' adherence to NRT
Butterworth 2014 North Solihull, England, UK; urban; pregnant and postpartum women; perceptions of smoking ces-
sation services
England 2016 Memphis (Tennessee), Philadelphia, (Pennsylvania), Oklahoma City (Oklahoma), Billings, (Mon-
tana), USA; urban; pregnant and postpartum women; perceptions of NRT and emerging tobacco
products
Hotham 2002 Australia; urban; pregnant women; pregnant smokers' barriers to cessation, attitudes to NRT and
perceptions of cessation counselling
Naughton 2013 Cambridgeshire and Suffolk, England, UK; urban and rural; pregnant and postpartum women; dis-
sonance and disengagement in pregnant smokers
Taylor 2010 UK; pregnant and postpartum women; beliefs about stop smoking services and NRT in pregnancy
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CERQual evidence profile: finding 3
 
Finding 3, NRT : women report concerns that using NRT during pregnancy is unsafe for the baby, due to perceived lack of infor-
mation about nicotine safety for the fetus.
Assessment for each CERQual component
Methodological limitations Minor concerns: 4 studies with moderate (unclear sampling procedure, insufficiently described da-
ta collection or analysis) and all 12 studies with minor
Coherence No or very minor concerns
Relevance No or very minor concerns





Ashwin 2010 England, UK; urban and rural; pregnant women; views on using NRT in pregnancy
Bauld 2017 England and Scotland, UK; urban and rural; pregnant and postpartum women; perspectives and
experiences of barriers to and facilitators of smoking cessation
Borland 2013 Ontario, Canada; urban and rural; pregnant and postpartum women; exploring adequacy of stop
smoking support for pregnant and postpartum women
Bovill 2018 Hunter and New England regions, Australia; pregnant and postpartum women; barriers to smoking
cessation support during pregnancy
Bowker 2016 England, UK; pregnant women; understanding pregnant smokers' adherence to NRT
Butterworth 2014 North Solihull, England, UK; urban; pregnant and postpartum women; perceptions of smoking ces-
sation services
England 2016 Memphis (TN), Philadelphia, (PA), Oklahoma City (OK), Billings, (MT), USA; urban; pregnant and
postpartum women; perceptions of NRT and emerging tobacco products
Glover 2012 North Island, New Zealand; urban and rural; pregnant women; pregnant Maori smokers' perception
of smoking cessation support
Hotham 2002 Australia; urban; pregnant women; pregnant smokers' barriers to cessation, attitudes to NRT and
perceptions of cessation counselling
Naughton 2013 Cambridgeshire and Suffolk, England, UK; urban and rural; pregnant and postpartum women; dis-
sonance and disengagement in pregnant smokers
Radley 2013 Tayside, Scotland, UK; pregnant women; outcomes and factors influencing uptake of an incentive
scheme for smoking cessation for pregnant smokers
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Taylor 2010 UK; pregnant and postpartum women; beliefs about stop smoking services and NRT in pregnancy
  (Continued)
 
CERQual evidence profile: finding 4
 
Finding 4, e-cigarettes : women believe that e-cigarettes are safer than smoking in the general population; they believe e-ciga-
rettes contain fewer harmful chemicals than traditional cigarettes.
Assessment for each CERQual component
Methodological limitations Minor concerns: 2 studies with moderate (insufficient description of data analysis and/or data col-
lection), all 5 studies minor issues
Coherence Moderate concerns: views varied within studies
Relevance No or very minor concerns
Adequacy Minor concerns: overall moderately rich data but some studies contributed very thin data; 1 study –
data from one participant only
Overall CERQual assessment




Bauld 2017 England and Scotland, UK; urban and rural; pregnant and postpartum women; perceptions of new
stop smoking interventions
Bowker 2018 UK; pregnant and postpartum women; views on and experiences of e-cigarettes
England 2016 Memphis (TN), Philadelphia, (PA), Oklahoma City (OK), Billings, (MT), USA; urban; pregnant and
postpartum women; perceptions of NRT and emerging tobacco products
Fallin 2016b USA; pregnant and postpartum women; smoking in pregnant women in treatment for opioid de-
pendence
Grant 2020 South Wales, UK; pregnant women; stigma of smoking during pregnancy
 
 
CERQual evidence profile: finding 5
 
Finding 5, e-cigarettes : women report concerns that e-cigarettes can deliver unsafe amount of nicotine (higher than a tradi-
tional cigarette), for example due to the belief that unlike smoking, vaping has no discernable end point.
Assessment for each CERQual component
 
Factors influencing the uptake and use of nicotine replacement therapy and e-cigarettes in pregnant women who smoke: a qualitative
evidence synthesis (Review)









Cochrane Database of Systematic Reviews
Methodological limitations Minor concerns: 2 studies with moderate (insufficient description of data analysis and/or collec-
tion) and all 3 with minor
Coherence Minor concerns due to opposing cases
Relevance Moderate concerns: data from 3 studies, 2 from USA and 1 from the UK, setting unclear in all stud-
ies
Adequacy Moderate concerns: data from 3 studies only, thin data
Overall CERQual assessment




Bowker 2018 UK; pregnant and postpartum women; views on and experiences of e-cigarettes
England 2016 Memphis (TN), Philadelphia, (PA), Oklahoma City (OK), Billings, (MT), USA; urban; pregnant and
postpartum women; perceptions of NRT and emerging tobacco products




CERQual evidence profile: finding 6
 
Finding 6, e-cigarettes : women report concerns that using e-cigarettes during pregnancy is unsafe for the baby, due to per-
ceived lack of information about nicotine safety for the fetus.
Assessment for each CERQual component
Methodological limitations No or very minor concerns
Coherence No or very minor concerns
Relevance Moderate concerns: data from 3 studies, 2 from USA and 1 from the UK, setting unclear in all stud-
ies
Adequacy Minor concerns: data from 3 studies, but overall moderately rich
Overall CERQual assessment
Moderate confidence Moderate concerns about relevance and minor concerns about adequacy
Contributing studies
Study Context
Bauld 2017 England and Scotland, UK; urban and rural; pregnant and postpartum women; perceptions of new
stop smoking interventions
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Bowker 2016 England, UK; pregnant women; understanding pregnant smokers' adherence to NRT
Bowker 2018 UK; pregnant and postpartum women; views on and experiences of e-cigarettes




CERQual evidence profile: finding 7
 
Finding 7 , NRT: women report concerns that NRT is as addictive as smoking.
Assessment for each CERQual component
Methodological limitations Minor concerns: 2 studies with moderate (insufficient description of data analysis and/or collec-
tion) and all 4 with minor
Coherence No or very minor concerns
Relevance Moderate concerns: data from 4 studies, 3 from the UK, in similar setting, 1 from USA
Adequacy Moderate concerns: 4 studies contributed, overall thin data
Overall CERQual assessment
Moderate confidence Moderate concerns about relevance and adequacy, minor concerns about methodological issues
Contributing studies
Study Context
Ashwin 2010 England, UK; urban and rural; pregnant women; views on using NRT in pregnancy
Bowker 2016 England, UK; pregnant women; understanding pregnant smokers' adherence to NRT
England 2016 Memphis (TN), Philadelphia, (PA), Oklahoma City (OK), Billings, (MT), USA; urban; pregnant and
postpartum women; perceptions of NRT and emerging tobacco products
Taylor 2010 UK; pregnant and postpartum women; beliefs about stop smoking services and NRT in pregnancy
 
 
CERQual evidence profile: finding 8
 
Finding 8, NRT : women who had positive experience with NRT, or heard from others about positive experiences with NRT be-
ing effective report greater readiness to use it in pregnancy
Assessment for each CERQual component
Methodological limitations Minor concerns: 1 study with moderate issues (insufficiently reported data collection and or/analy-
sis) and all 5 with minor issues.
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Coherence No or very minor concerns
Relevance Moderate concerns: all from the UK
Adequacy Minor concerns: 5 studies contributing overall thin data
Overall CERQual assessment




Bauld 2017 England and Scotland, UK; urban and rural; pregnant and postpartum women; perspectives and
experiences of barriers to and facilitators of smoking cessation
Bowker 2016 England, UK; pregnant women; understanding pregnant smokers' adherence to NRT
Butterworth 2014 North Solihull, England, UK; urban; pregnant and postpartum women; perceptions of smoking ces-
sation services
Pledger 2015 UK; pregnant and postpartum women; exploring pregnant smokers' experiences using an NHS stop
smoking service
Taylor 2010 UK; pregnant and postpartum women; beliefs about stop smoking services and NRT in pregnancy
  (Continued)
 
CERQual evidence profile: finding 9
 
Finding 9, NRT : women who had past negative experiences with NRT, or heard from others who had negative experiences with
NRT being ineffective,were reluctant to use NRT in pregnancy.
Assessment for each CERQual component
Methodological limitations Moderate concerns: 6 studies with moderate (insufficiently rigorous description or conduct of data
collection and/or analysis) and all 9 with minor
Coherence No or very minor concerns
Relevance No or very minor concerns
Adequacy Minor concerns: 3 studies contributed very thin data, but overall moderately rich data from all
studies
Overall CERQual assessment
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Ashwin 2010 England, UK; urban and rural; pregnant women; views on using NRT in pregnancy
Bauld 2017 England and Scotland, UK; urban and rural; pregnant and postpartum women; perspectives and
experiences of barriers to and facilitators of smoking cessation
Bowker 2016 England, UK; pregnant women; understanding pregnant smokers' adherence to NRT
England 2016 Memphis (TN), Philadelphia, (PA), Oklahoma City (OK), Billings, (MT), USA; urban; pregnant and
postpartum women; perceptions of NRT and emerging tobacco products
Fallin 2016a Kentucky, USA; pregnant and postpartum women; perceptions of e-cigarettes
Hotham 2002 Australia; urban; pregnant women; pregnant smokers' barriers to cessation, attitudes to NRT and
perceptions of cessation counselling
Mantzari 2012 Birmingham, England, UK; urban; pregnant and postpartum women; effectiveness of financial in-
centives for smoking cessation during pregnancy
Pledger 2015 UK; pregnant and postpartum women; exploring pregnant smokers' experiences using an NHS stop
smoking service
Taylor 2010 UK; pregnant and postpartum women; beliefs about stop smoking services and NRT in pregnancy
  (Continued)
 
CERQual evidence profile: finding 10
 
Finding 10, e-cigarette : women present mixed views on effectiveness of e-cigarettes.
Assessment for each CERQual component
Methodological limitations No or very minor concerns
Coherence No or very minor concerns
Relevance Moderate concerns: 4 studies, all from the UK, from similar setting
Adequacy Serious concerns: overall very thin data from 2 studies and limited contributions from 2 studies
Overall CERQual assessment
Low confidence Serious concerns about adequacy and moderate concerns about relevance
Contributing studies
Study Context
Bauld 2017 England and Scotland, UK; urban and rural; pregnant and postpartum women; perceptions of new
stop smoking interventions
Bowker 2016 England, UK; pregnant women; understanding pregnant smokers' adherence to NRT
Bowker 2018 UK; pregnant and postpartum women; views on and experiences of e-cigarettes
Grant 2020 South Wales, UK; pregnant women; stigma of smoking during pregnancy
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CERQual evidence profile: finding 11
 
Finding 11, NRT : women report that experiencing and feeling unable to deal with side effects of NRT is a barrier to using it in
pregnancy.
Assessment for each CERQual component
Methodological limitations Moderate concerns: 5 studies with moderate (relating to insufficiently rigorous description or con-
duct of data collection and/or analysis) and all 9 with minor issues
Coherence No or very minor concerns
Relevance No or very minor concerns





Ashwin 2010 England, UK; urban and rural; pregnant women; views on using NRT in pregnancy
Bauld 2017 England and Scotland, UK; urban and rural; pregnant and postpartum women; perspectives and
experiences of barriers to and facilitators of smoking cessation
Bovill 2018 Hunter and New England regions, Australia; pregnant and postpartum women; barriers to smoking
cessation support during pregnancy
Bowker 2016 England, UK; pregnant women; understanding pregnant smokers' adherence to NRT
Butterworth 2014 North Solihull, England, UK; urban; pregnant and postpartum women; perceptions of smoking ces-
sation services
England 2016 Memphis (TN), Philadelphia, (PA), Oklahoma City (OK), Billings, (MT), USA; urban; pregnant and
postpartum women; perceptions of NRT and emerging tobacco products
Mantzari 2012 Birmingham, England, UK; urban; pregnant and postpartum women; effectiveness of financial in-
centives for smoking cessation during pregnancy
Pledger 2015 UK; pregnant and postpartum women; exploring pregnant smokers' experiences using an NHS stop
smoking service
Taylor 2010 UK; pregnant and postpartum women; beliefs about stop smoking services and NRT in pregnancy
 
 
CERQual evidence profile: finding 12
 
Finding 12, NRT : women report that receiving clear and consistent reassurance from health professionals about NRT safety in
pregnancy can facilitate NRT use.
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Assessment for each CERQual component
Methodological limitations Minor concern: 2 studies with moderate (insufficient reporting and/or conduct of data collection or
analysis) and all 6 with minor issues
Coherence No or very minor concerns
Relevance Minor concerns: 4 studies from the UK, but varied settings, 2 studies from Australia
Adequacy Minor concerns: some studies contributed very thin data
Overall CERQual assessment
Moderate confidence Minor concerns about methodological issues, relevance and adequacy
Contributing studies
Study Context
Ashwin 2010 England, UK; urban and rural; pregnant women; views on using NRT in pregnancy
Bauld 2017 England and Scotland, UK; urban and rural; pregnant and postpartum women; perspectives and
experiences of barriers to and facilitators of smoking cessation
Bowker 2016 England, UK; pregnant women; understanding pregnant smokers' adherence to NRT
Gamble 2015 Australia; pregnant women; pregnant women's experiences of smoking cessation interventions
Hotham 2002 Australia; urban; pregnant women; pregnant smokers' barriers to cessation, attitudes to NRT and
perceptions of cessation counselling
Taylor 2010 UK; pregnant and postpartum women; beliefs about stop smoking services and NRT in pregnancy
  (Continued)
 
CERQual evidence profile: finding 13
 
Finding 13, NRT : women report that experiencing lack of support towards NRT use in pregnancy from health professionals is a
barrier to NRT use.
Assessment for each CERQual component
Methodological limitations Moderate concerns: 7 studies with moderate (insufficient reporting and/or conduct of data collec-
tion or analysis; findings insufficiently substantiated by the data), all 11 studies with minor issues.
Coherence No or very minor concerns
Relevance No or very minor concerns
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Contributing studies
Study Context
Borland 2013 Ontario, Canada; urban and rural; pregnant and postpartum women; exploring adequacy of stop
smoking support for pregnant and postpartum women
Bovill 2018 Hunter and New England regions, Australia; pregnant and postpartum women; barriers to smoking
cessation support during pregnancy
Bowker 2016 England, UK; pregnant women; understanding pregnant smokers' adherence to NRT
Gamble 2015 Australia; pregnant women; pregnant women's experiences of smoking cessation interventions
Glover 2012 North Island, New Zealand; urban and rural; pregnant women; pregnant Maori smokers' perception
of smoking cessation support
Hauck 2013 Perth, Australia; urban; pregnant women; challenges and enablers to smoking cessation for preg-
nant smokers
Herbec 2014 UK; pregnant women; needs and preferences of pregnant smokers regarding internet based smok-
ing cessations
Hotham 2002 Australia; urban; pregnant women; pregnant smokers' barriers to cessation, attitudes to NRT and
perceptions of cessation counselling
Mantzari 2012 Birmingham, England, UK; urban; pregnant and postpartum women; effectiveness of financial in-
centives for smoking cessation during pregnancy
Pledger 2015 UK; pregnant and postpartum women; exploring pregnant smokers' experiences using an NHS stop
smoking service
Taylor 2010 UK; pregnant and postpartum women; beliefs about stop smoking services and NRT in pregnancy
  (Continued)
 
CERQual evidence profile: finding 14
 
Finding 14, NRT : women feel discouraged from NRT use in pregnancy by the perceived views and experiences of other people
(non-health-professionals).
Assessment for each CERQual component
Methodological limitations Minor concerns: 2 studies with moderate issues relating to data collection and or/analysis and all 4
with minor methodological issues
Coherence No or very minor concerns
Relevance Minor concerns: data from 4 studies, but from three continents
Adequacy Moderate concerns: most data from 1 study, supported by the other 3 (fairly thin data)
Overall CERQual assessment
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Bovill 2018 Hunter and New England regions, Australia; pregnant and postpartum women; barriers to smoking
cessation support during pregnancy
England 2016 Memphis (TN), Philadelphia, (PA), Oklahoma City (OK), Billings, (MT), USA; urban; pregnant and
postpartum women; perceptions of NRT and emerging tobacco products
Hotham 2002 Australia; urban; pregnant women; pregnant smokers' barriers to cessation, attitudes to NRT and
perceptions of cessation counselling
Taylor 2010 UK; pregnant and postpartum women; beliefs about stop smoking services and NRT in pregnancy
  (Continued)
 
CERQual evidence profile: finding 15
 
Finding 15, e-cigarettes : women's readiness to use e-cigarettes in pregnancy is influenced by the advice they report receiving
from health professionals.
Assessment for each CERQual component
Methodological limitations No or very minor concerns
Coherence Minor concerns: a few opposing cases
Relevance Minor concerns: 4 studies from the UK, 1 from USA, context unclear in some





Bauld 2017 England and Scotland, UK; urban and rural; pregnant and postpartum women; perceptions of new
stop smoking interventions
Bowker 2016 England, UK; pregnant women; understanding pregnant smokers' adherence to NRT
Bowker 2018 UK; pregnant and postpartum women; views on and experiences of e-cigarettes
Fallin 2016b USA; pregnant and postpartum women; smoking in pregnant women in treatment for opioid de-
pendence
Grant 2020 South Wales, UK; pregnant women; stigma of smoking during pregnancy
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CERQual evidence profile: finding 16
 
Finding 16, e-cigarettes : women's readiness to use e-cigarettes in pregnancy is influenced by other people (non-health profes-
sionals).
Assessment for each CERQual component
Methodological limitations No or very minor concerns
Coherence No or very minor concerns
Relevance Moderate concerns: 3 studies contributed data, all from UK
Adequacy Moderate concerns: very thin data from small number of studies
Overall CERQual assessment
Moderate confidence Moderate concerns about relevance and adequacy
Contributing studies
Study Context
Bauld 2017 England and Scotland, UK; urban and rural; pregnant and postpartum women; perceptions of new
stop smoking interventions
Bowker 2018 UK; pregnant and postpartum women; views on and experiences of e-cigarettes
Grant 2020 South Wales, UK; pregnant women; stigma of smoking during pregnancy
 
 
CERQual evidence profile: finding 17
 
Finding 17, NRT : perceived characteristics of the NRT product, such as cost, convenience, ability to mimic a cigarette can influ-
ence uptake and continuous use of NRT in pregnancy
Assessment for each CERQual component
Methodological limitations Moderate concerns: 6 studies with moderate issues relating to data collection and or/analysis and
all 12 with minor methodological issues
Coherence No or very minor concerns
Relevance No or very minor concerns
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Study Context
Ashwin 2010 England, UK; urban and rural; pregnant women; views on using NRT in pregnancy
Bauld 2017 England and Scotland, UK; urban and rural; pregnant and postpartum women; perspectives and
experiences of barriers to and facilitators of smoking cessation
Bowker 2016 England, UK; pregnant women; understanding pregnant smokers' adherence to NRT
Bowker 2018 UK; pregnant and postpartum women; views on and experiences of e-cigarettes
Butterworth 2014 North Solihull, England, UK; urban; pregnant and postpartum women; perceptions of smoking ces-
sation services
England 2016 Memphis (TN), Philadelphia, (PA), Oklahoma City (OK), Billings, (MT), USA; urban; pregnant and
postpartum women; perceptions of NRT and emerging tobacco products
Fallin 2016a Kentucky, USA; pregnant and postpartum women; perceptions of e-cigarettes
Fallin 2016b USA; pregnant and postpartum women; smoking in pregnant women in treatment for opioid de-
pendence
Hotham 2002 Australia; urban; pregnant women; pregnant smokers' barriers to cessation, attitudes to NRT and
perceptions of cessation counselling
Pledger 2015 UK; pregnant and postpartum women; exploring pregnant smokers' experiences using an NHS stop
smoking service
Radley 2013 Tayside, Scotland, UK; pregnant women; outcomes and factors influencing uptake of an incentive
scheme for smoking cessation for pregnant smokers
Taylor 2010 UK; pregnant and postpartum women; beliefs about stop smoking services and NRT in pregnancy
  (Continued)
 
CERQual evidence profile: finding 18
 
Finding 18, e-cigarette : perceived characteristics of e-cigarettes, such as cost, convenience, ability to mimic a cigarette can influ-
ence uptake and continuous use of e-cigarettes in pregnancy
Assessment for each CERQual component
Methodological limitations Minor concerns: 2 studies with moderate (relating to reporting or conduct of data collection and/or
analysis) and all 4 studies with minor issues
Coherence No or very minor concerns
Relevance Minor concerns: 4 studies contributed data, from 2 continents, setting often unclear
Adequacy Minor concerns: overall moderately rich data, but from four studies only.
Overall CERQual assessment
Moderate confidence Minor concerns about methodological issues, relevance and adequacy
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Contributing studies
Study Context
Bauld 2017 England and Scotland, UK; urban and rural; pregnant and postpartum women; perceptions of new
stop smoking interventions
Bowker 2018 UK; pregnant and postpartum women; views on and experiences of e-cigarettes
England 2016 Memphis (TN), Philadelphia, (PA), Oklahoma City (OK), Billings, (MT), USA; urban; pregnant and
postpartum women; perceptions of NRT and emerging tobacco products




Appendix 6. Integration of the QES findings with descriptions of interventions described in e6ectiveness trials
included in Cochrane review (Coleman 2015; updated Claire 2020)
 
Key QES findings Description of the intervention from clinical trials
Study Berlin 2014
Was the advice on NRT delivered by a health professional trained in
smoking cessation? (Finding 12, finding 13)
Yes - Doctor or nurse with a diploma in smoking cessa-
tion
Was the advice delivered consistently throughout pregnancy? (Finding
12, finding 13)
Intervention – up to 7 visits, 1st - 1 h of behavioural sup-
port for smoking cessation, then at least 10 minutes; re-
minder to use NRT at each visit
Impossible to determine what information women re-
ceived from other health professionals throughout the
routine antenatal pathway
Was the strength of NRT appropriate to the level of addiction to best
help manage cravings? (Finding 8, finding 9)
Yes - patch strength assigned based on salivary cotinine
level
Were women given a choice of NRT to best suit their needs? (Finding
11, finding 17)
No – all women received patches
Was safety of NRT in pregnancy discussed, with reassurance that NRT
is safer for the developing baby than smoking? (Finding 1, finding 2,
finding 3, finding 7)
Unclear if and/or in how much detail
Were clear instructions and support given on how to use NRT effective-
ly? (Finding 8, finding 9)
Yes
Women were also encouraged to stay on the patch dur-
ing lapses
Was preparation for/coping with side effects and practical issues with
NRT discussed? (Finding 11)
Unclear if and/or in how much detail
Study Coleman 2012
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Was the advice on NRT delivered by a health professional trained in
smoking cessation? (Finding 12, finding 13)
Yes - trained research midwives, with use of smoking
cessation manual
Was the advice delivered consistently throughout pregnancy? (Finding
12, finding 13)
Intervention – up to 4 behavioural support sessions, 1st
– 1 h face to face, then over the telephone
Women were encouraged to ask for further support
from research midwives and to access NHS stop smok-
ing services
Impossible to determine what information women re-
ceived from other health professionals throughout the
routine antenatal pathway
Was the strength of NRT appropriate to the level of addiction to best
help manage cravings? (Finding 8, finding 9)
No – all women received the same strength at the onset
Were women given a choice of NRT to best suit their needs? (Finding
11, finding 17)
No – all women received patches
Was safety of NRT in pregnancy discussed, with reassurance that NRT
is safer for the developing baby than smoking? (Finding 1, finding 2,
finding 3, finding 7)
Unclear if and/or in how much detail
Were clear instructions and support given on how to use NRT effective-
ly? (Finding 8, finding 9)
Unclear if and/or in how much detail
Was preparation for/coping with side effects and practical issues with
NRT discussed? (Finding 11)
Unclear if and/or in how much detail
Study El-Mohandes 2013
Was the advice on NRT delivered by a health professional trained in
smoking cessation? (Finding 12, finding 13)
Trial staG, unclear who
Was the advice delivered consistently throughout pregnancy? (Finding
12, finding 13)
5 behavioural support sessions, 5 As Model based
counselling;
Impossible to determine what information women re-
ceived from other health professionals throughout the
routine antenatal pathway
Was the strength of NRT appropriate to the level of addiction to best
help manage cravings? (Finding 8, finding 9)
Yes - patch strength assigned based on salivary cotinine
level
Were women given a choice of NRT to best suit their needs? (Finding
11, finding 17)
No – all women received patches
Was safety of NRT in pregnancy discussed, with reassurance that NRT
is safer for the developing baby than smoking? (Finding1, finding2,
finding 3, finding 7)
Unclear if and/or in how much detail
Were clear instructions and support given on how to use NRT effective-
ly? (Finding 8, finding 9)
Yes - participants were given clear verbal and written
instructions on patch use. They were advised never
to smoke while using the patch, to remove the patch
before going to sleep and never to use other NRT
method(s).
  (Continued)
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Was preparation for/coping with side effects and practical issues with
NRT discussed? (Finding 11)
Unclear if and/or in how much detail
Study Hotham 2006
Was the advice on NRT delivered by a health professional trained in
smoking cessation? (Finding 12, finding 13)
Researcher or by one of the part-time researcher offi-
cers, midwives who had undergone specialised cessa-
tion training
Was the advice delivered consistently throughout pregnancy? (Finding
12, finding 13)
5 minutes counselling at 1st visit, plus < 2 min coun-
selling at subsequent visits
Impossible to determine what information women re-
ceived from other health professionals throughout the
routine antenatal pathway
Was the strength of NRT appropriate to the level of addiction to best
help manage cravings? (Finding 8, finding 9)
No – all women received the same strength NRT at on-
set
Were women given a choice of NRT to best suit their needs? (Finding
11, finding 17)
No – all women received patches
Was safety of NRT in pregnancy discussed, with reassurance that NRT
is safer for the developing baby than smoking? (Finding1, finding2,
finding 3, finding 7)
Unclear if and/or in how much detail
Were clear instructions and support given on how to use NRT effective-
ly? (Finding 8, finding 9)
Women received the patch with "use instructions"
Was preparation for/coping with side effects and practical issues with
NRT discussed? (Finding 11)
Unclear if and/or in how much detail
Study Kapur 2001
Was the advice on NRT delivered by a health professional trained in
smoking cessation? (Finding 12, finding 13)
1st session – a non-personalised video message plus 3
counselling sessions, unclear with whom
Impossible to determine what information women re-
ceived from other health professionals throughout the
routine antenatal pathway
Was the advice delivered consistently throughout pregnancy? (Finding
12, finding 13)
4 sessions, unclear with whom, weekly telephone con-
tact
Was the strength of NRT appropriate to the level of addiction to best
help manage cravings? (Finding 8, finding 9)
No – all women received the same strength at the onset
Were women given a choice of NRT to best suit their needs? (Finding
11, finding 17)
No – all women received patches
Was safety of NRT in pregnancy discussed, with reassurance that NRT
is safer for the developing baby than smoking? (Finding1, finding2,
finding 3, finding 7)
Unclear if and/or in how much detail
Were clear instructions and support given on how to use NRT effective-
ly? (Finding 8, finding 9)
Unclear if and/or in how much detail
  (Continued)
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Was preparation for/coping with side effects and practical issues with
NRT discussed? (Finding 11)
Unclear if and/or in how much detail
Study Oncken 2008
Was the advice on NRT delivered by a health professional trained in
smoking cessation? (Finding 12, finding 13)
Yes - research assistant trained to deliver smoking ces-
sation counselling. In addition to the counselling ses-
sions, subjects received printed educational materi-
als that were tailored for use in pregnancy and twice-
monthly telephone calls to monitor progress until de-
livery
Was the advice delivered consistently throughout pregnancy? (Finding
12, finding 13)
Up to 9 sessions of behavioural support of up to 35
minutes per session
Was the strength of NRT appropriate to the level of addiction to best
help manage cravings? (Finding 8, finding 9)
No – all women received the same strength at the onset
Were women given a choice of NRT to best suit their needs? (Finding
11, finding 17)
No – all women received gum
Was safety of NRT in pregnancy discussed, with reassurance that NRT
is safer for the developing baby than smoking? (Finding1, finding2,
finding 3, finding 7)
Unclear if and/or in how much detail
Were clear instructions and support given on how to use NRT effective-
ly? (Finding 8, finding 9)
Unclear if and/or in how much detail
Was preparation for/coping with side effects and practical issues with
NRT discussed? (Finding 11)
Unclear if and/or in how much detail
Study Oncken 2019
Was the advice on NRT delivered by a health professional trained in
smoking cessation? (Finding 12, finding 13)
Yes - study nurse who was trained to deliver the coun-
selling using a motivational interviewing approach,
written educational materials on smoking cessation
during pregnancy and the package insert for the nico-
tine inhalator
Was the advice delivered consistently throughout pregnancy? (Finding
12, finding 13)
3 counselling sessions, up to 35 minutes,
Impossible to determine what information women re-
ceived from other health professionals throughout the
routine antenatal pathway
Was the strength of NRT appropriate to the level of addiction to best
help manage cravings? (Finding 8, finding 9)
Inhalator strength assigned based on nicotine depen-
dence level (CPD)
Were women given a choice of NRT to best suit their needs? (Finding
11, finding 17)
No – all women received an inhalator
Was safety of NRT in pregnancy discussed, with reassurance that NRT
is safer for the developing baby than smoking? (Finding 1, finding 2,
finding 3, finding 7)
Unclear if and/or in how much detail
Were clear instructions and support given on how to use NRT effective-
ly? (Finding 8, finding 9)
Women received the package insert for the nicotine in-
halator
  (Continued)
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Was preparation for/coping with side effects and practical issues with
NRT discussed? (Finding 11)
Unclear if and/or in how much detail
Study Pollak 2007
Was the advice on NRT delivered by a health professional trained in
smoking cessation? (Finding 12, finding 13)
Yes – support specialists, but unclear who
Was the advice delivered consistently throughout pregnancy? (Finding
12, finding 13)
6 counselling sessions, 5 face to face, 1 telephone, plus
a "quit kit" including various cessation aids
Impossible to determine what information women re-
ceived from other health professionals throughout the
routine antenatal pathway
Was the strength of NRT appropriate to the level of addiction to best
help manage cravings? (Finding 8, finding 9)
Yes - patch strength assigned depending on nicotine
dependence (CPD)
Were women given a choice of NRT to best suit their needs? (Finding
11, finding 17)
Gum, patch or lozenge with support to make an in-
formed choice at the onset of the study Unclear if able
to change if not happy with their choice
Was safety of NRT in pregnancy discussed, with reassurance that NRT
is safer for the developing baby than smoking? (Finding 1, finding 2,
finding 3, finding 7)
Unclear if and/or in how much detail
Were clear instructions and support given on how to use NRT effective-
ly? (Finding 8, finding 9)
At one session, advantages and disadvantages of these
3 NRT modes were discussed and women were sup-
ported in making a choice
Was preparation for/coping with side effects and practical issues with
NRT discussed? (Finding 11)
Unclear if and/or in how much detail
Study Wisborg 2000
Was the advice on NRT delivered by a health professional trained in
smoking cessation? (Finding 12, finding 13)
Yes – midwife independent of antenatal care
Was the advice delivered consistently throughout pregnancy? (Finding
12, finding 13)
4 behavioural support sessions plus a pamphlet
Impossible to determine what information women re-
ceived from other health professionals throughout the
routine antenatal pathway
Was the strength of NRT appropriate to the level of addiction to best
help manage cravings? (Finding 8, finding 9)
No – all women received the same strength NRT at on-
set
Were women given a choice of NRT to best suit their needs? (Finding
11, finding 17)
No
Was safety of NRT in pregnancy discussed, with reassurance that NRT
is safer for the developing baby than smoking? (Finding 1, finding 2,
finding 3, finding 7)
Unclear if and/or in how much detail
Were clear instructions and support given on how to use NRT effective-
ly? (Finding 8, finding 9)
Unclear if and/or in how much detail
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Was preparation for/coping with side effects and practical issues with
NRT discussed? (Finding 11)
Unclear if and/or in how much detail
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